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Abstract (German) 
 
Proteine sind für nahezu alle zellulären Prozesse verantwortlich. Selbst wenn ihre 
Vielfältigkeit an Grössen und Formen endlos zu sein erscheint, können Proteine jedoch in 
kleinere Einheiten namens Domäne unterteilt werden. Wie diese Domänen entstanden sind, ist 
zur Zeit nicht ganz klar. Mehrere Hypothesen gehen davon aus, dass sie aus der Kombination 
von kleineren Fragmenten resultieren., Obwohl Proteine global gesehen sehr unterschiedliche 
Formen annehmen, findet man tatsächlich lokale Ähnlichkeiten auf Sequenz- und Struktur- 
Ebene. Daher haben wir nach homologen Fragmenten unterschiedlicher Faltung gesucht und 
fanden, dass viele Domänen der α/β-Proteinklasse von SCOP homologe Fragmente von einem 
Dutzend bis >200 Aminosäuren teilen. Ein besonders interessanter Fall stellte die HemD-
ähnliche Faltung dar, da ihre Sequenz-Profile auf Genduplikation, Insertion und Segment-
Swap von einer Flavodoxin-ähnlichen Faltung hinwies. Um diese Hypothese zu testen, kehrte 
ich diese evolutiven Schritte experimentell um und fand, dass das mutmaßliche ursprüngliche 
Protein in der Tat die Flavodoxin-ähnliche Topologie aufwies. Diese Ergebnisse 
veranschaulichen die Strategie der Natur, bei der die Kombination einer reduzierten Anzahl 
an Fragmenten eine weitaus größere Vielfältigkeit an Strukturen ermöglicht. Unter der 
Annahme, dass homologe Fragmente sich leichter kombinieren lassen, stellte ich eine 
Faltungschimäre her. Dabei tauschte ich ein Fragment, welches Teil der Cobalamin bindenden 
Tasche der Flavodoxin-like Faltung enthielt und baute dieses in die HemD-ähnliche Faltung 
hinein. Die Proteinchimäre war gefaltet und wies native Eigenschaften auf, was die 
Aufklärung ihrer Struktur mittels Kristallographie ermöglichte. Bindungsanalysen wiesen 
darauf hin, dass die Faltungschimäre Cobalamin bindet. Allgemein zeigen die Ergebnisse, 
dass die Kombination homologer Fragmente ausgenutzt werden kann, um Bindungstaschen 
von komplexen Kofaktoren zu transferieren und damit das Design von neuen Katalysatoren 
zu designen.  
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Abstract (English) 
 
Whilst the structural diversity of proteins may appear endless, even large protein complexes 
can be decomposed into their independently folding units, the domains. Little is known about 
domain emergence. Structural and sequence evidence suggests they evolved through 
combination of subdomain-sized fragments. To investigate this hypothesis, we searched for 
homologous regions among domains with a broadly different topology (fold), employing the 
α/β-class as defined in the Structural Classification Of Proteins (SCOP), which is believed to 
contain the oldest domains. We compared their sequence profiles all-against-all and found 
that in spite of their globally different architectures a large number of them share local 
homologous regions ranging from a dozen to >200 amino acids. An interesting hit constitutes 
the hemD-like fold, whose profile alignments provide strong evidence for its emergence via 
flavodoxin-like gene duplication, insertion and segment-swapping. To test this hypothesis 
experimentally, we reverted these evolutionary events, finding that the obtained protein in fact 
adopts the canonical flavodoxin-like fold. These results illustrate a way how Nature recycles a 
limited repertoire of building blocks, which provides a successful strategy to reach diversity at 
a lower molecular cost than creating every unit de novo. Such building units may have 
overcome a selective pressure through the course of evolution due to their function and/or 
intrinsic stability that allowed them to be modified and extended. Inspired by this naturally 
occurring strategy, I designed a cobalamin-binding chimera, extracting a portion of the 
binding pocket of a cobalamin-binding domain and exchanged it against its homologous 
region in the hemD-like fold. The resulting chimera expresses solubly, is well folded and 
binds cobalamin, illustrating that mimicking Nature’s combinatorial approach is a good 
source of soluble and well-folded proteins and may be employed as an alternative strategy to 
design novel functionalities. 
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Chapter 1 
Introduction 
 
1.1. Protein emergence as RNA cofactors 
  
Approximately 4.2 billion years ago, the first prebiotic molecules appeared to provide the 
chemical conditions that would initiate the most beautiful accident of nature: life (Figure 1.1).  
In the beginning of life, however, proteins did not play a major role as they do now. In fact, 
lacking complexity and self-replicating properties such these of RNA (Kiedrowski and von 
Kiedrowski 1986), small peptides may have assisted an RNA-organized world (Gilbert 1986; 
Gerald F. Joyce 1989), helping to expand the limited chemical functionalities of ribozymes 
(Roth and Breaker 1998; G. F. Joyce 1998) as for instance, chelating valuable metals to be 
used in catalysis. Thus, RNA and peptides may have cooperated closely to allow the synthesis 
of larger and more complex polymers, from which the most resistant overcame extinction 
through improvement of their replication/degradation rates. As simple as it may appear, via 
trial and error, proteins were optimized to become fundamental chemical agents that drive 
nearly all functions necessary to sustain life.  
 
 
 
Figure 1.1 Timeline of events pertaining to the early history of life on Earth, with approximate dates in 
billions of years before the present. Adapted from “The antiquity of RNA-based evolution” by Gerald F. 
Joyce, Nature, 418, page 214 (2002).   
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1.2.  From small peptides to proteins 
 
The details on how small peptides evolved into larger and more sophisticated proteins remain 
mainly unsolved. However, footprints hidden in the sequences and structures of modern 
proteins provide hints about their origin. Margaret O. Dayhoff and Richard Eck were the first 
to recognize the internal symmetry of ferredoxin, suggesting that its periodic content may be 
the result of internal gene duplication of short peptides (Eck and Dayhoff 1966). Subsequently 
in 1973, repeating units ranging from 2 to 7 residues were described by  Fraser and colleagues 
for proteins such as collagen, silk fibroin, keratin and tropomyosin (Jorda et al. 2010). Five 
years later, Andrew McLachlan described the three-fold repetition pattern in the soybean 
trypsin inhibitor (McLachlan 1979). These pioneer works established the groundwork for the 
following half century of studying the underlying principles of protein evolution, supporting 
the idea that early proteins had to be simple. Thus, in the absence of a fine-tuned translational 
machinery, the combination of small peptides may have been a good strategy to gain size at a 
low molecular cost. However, not only ancient proteins seem to have been created via this 
strategy. A recently evolved arctic cod fish antifreeze protein also emerged from repetition of 
a three-peptide repeat. These threonine-containing units allow glycosylation on the protein 
surface, preventing formation of ice latices (Baalsrud et al. 2017). Another type of recently 
evolved repeat proteins are solenoids (Kobe and Kajava 2000). They result from the 
duplication of structural ɑ/ɑ, β/β or ɑ/β elements that belong to the so termed ‘supersecondary 
structural elements’, which have been described in detail (Murzin 1995, Koonin EV 2012, 
Thorton 1999, Russell 2002). The addition of tandem repeats usually yields linear arrays such 
as the Iafp protein or superhelicalical architectures as HEAT. The fact that these structures 
have large areas accessible to solvent, provide binding surfaces for large substrates. In some 
cases however, tandem repeats reach globular architectures such as these of the TIM-barrel 
and β-propellers (Andrade, Perez-Iratxeta, and Ponting 2001). The advantage of these circular 
arrangements is that they provide with relatively small binding areas for interaction with 
smaller ligands. Another advantage of globular proteins is that they are compact and 
commonly stable.  
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Previous studies have demonstrated that it is possible to recreate TIM-barrels by duplicating 
one of its halves (Höcker, Claren, and Sterner 2004) or even taking a fragment from the 
flavodoxin-like fold, suggesting that the TIM-barrel emerged through duplication and fusion 
of a smaller unit, which may have given rise to the flavodoxin-like fold in parallel (Farías-
Rico, Schmidt, and Höcker 2014; Bharat et al. 2008; Coles et al. 2012). A recent study also 
recreated the evolution of β-propellers by duplicating and fusing one of its blades and 
subjecting it to divergence. The results demonstrated that the introduction of mutations had a 
positive impact on the protein stability and binding (Smock et al. 2016), which shows why 
perfect repeats are rarely found in Nature. However, other cases of proteins that evolved 
through gene duplication and kept high sequence identity of their repeating units can also be 
found. One example are the ferredoxins, which have been widely cited as evidence of gene 
duplication since their halves are almost identical and display periodic arrangements of 
cysteines (George et al. 1985, Bruschi and Guerlesquin 1988). Such proven cases of 
duplication are of great value since they indicate the existence of a vocabulary of fragments 
smaller than the protein domain from which many proteins may have derived and illustrate 
how their enlargement through duplication provided the opportunity to broaden cellular 
functions (Figure 1.2). These hypothesis correlates with the fact that even though repeats are 
common in all phylia, they are more represented in eukaryotic than in prokaryotic organisms 
(Marcotte et al. 1999).   
 
 
Fig.1.2 Protein from pieces. Duplication of small structural elements is a common evolutionary strategy to gain 
size and complexity, leading to larger architectures that are capable to perform novel functions not observed for 
their repeating units alone.  
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1.3. The domain as an evolutionary unit 
 
A highly significant contribution to the understanding of proteins has been made by structural 
biology: X-Ray crystallography, nuclear magnetic resonance, and more recently Cryo-EM 
techniques. In the course of the last 60 years, more than 40 000 unique protein structures have 
been solved (Berman 2000), broadening our understanding on their functions and 
organization. In the light of this large amount of three-dimensional information, it was noticed 
that even large protein complexes could be decomposed into independently-folding units, 
termed domains (Figure 1.3). Each domain performs a certain function and this task is 
usually maintained even if the domain is extracted from its protein complex. In Nature, 
domains can be found as single units as well as part of larger polypeptide chains. A protein 
complex can contain two or more copies of the same unit or a combination of different ones. 
One example constitutes the vitamin B12-binding domain. This module expresses separately 
from its domain counterpart and later associates with it to build the glutamate mutase 
(Hoffmann et al. 1999). In contrast, in proteins such as the methionine synthase (Matthews, 
Koutmos, and Datta 2008) and the photoreceptor CarH (Z. Cheng, Yamamoto, and Bauer 
2016; Jost et al. 2015), it is embedded in the same polypeptide chain adjacent to their coacting 
domains. Embedded or isolated, the vitamin B12-binding domain performs the same task in 
all these proteins, namely to bind cobalamin. However, the reaction outcome is different in all 
of them: methylation, isomerization and cobalamin-dependent oligomerization, respectively. 
The fact that a certain function can be reused and combined with others to reach diversity, 
postulated the domain as the evolutionary unit par excellence, and illustrated the principle of 
domain shuffling (Babushok, Ostertag, and Kazazian 2007; Chothia et al. 2003). After the 
discovery of domains and their crucial role in evolution, the next obvious question arose. 
Where do these domains come from? Are they related to each other or emerged 
independently? Recent research postulates that both events are possible, although the latter is 
much less common.  
 13 
  
 
Figure 1.3 The domain as the evolutionary unit of proteins. Even large protein complexes can be 
decomposed into domains (represented in different colors). These domains usually function independently and 
can be combined with others to reach diversity. For instance, the cobalamin-binding domain (green) employs 
cobalamin to perform diverse functionalities.  
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1.4. Duplication and divergence as a common evolutionary strategy to achieve 
functional diversity 
 
The most common type of evolutionary events through which domains emerge is gene 
duplication (Lupas, Ponting, and Russell 2001; Chothia and Gough 2009). Hereby, the 
duplicated unit is free to explore new functionalities without functional pressure, since the 
original copy maintains the essential function. Through mutations, the sequences of the 
derived domains change. Nevertheless, they usually keep similar architectures and topologies. 
This is the reason why structure is more conserved than sequence, which is also reflected in 
the large number of domains that adopt the same structure, even though they perform different 
activities. Particularly in bacteria and archaea, 35% of the enzymatic activities are carried out 
by only one structural domain (Orengo and Thornton 2005) and even though duplication 
events have been reported for all species, the animal kingdom is located at the top with 93% 
of estimated duplications, followed by fungi and bacteria with 85 and 50%, respectively 
(Chothia et al. 2003). Occasionally, duplicated domains experience circular permutations, a 
process by which a domain achieves a new topology while keeping its intact architecture. It is 
estimated that 5% of all domains resulted in this manner (Vogel and Morea 2006). Deletions 
and insertions also play an important role in the diversification of domains. For instance, 
adding decorations to a protein may facilitate the taking part in allosteric regulation and 
protein-protein interactions. However, insertions within the core of proteins are expected to 
affect their stability. Perhaps, this is the reason for why these events occur less frequently, 
accounting for one order of magnitude frequency reduction compared to mutations (Grishin 
2001). Even though gene duplication and diversification are common processes in evolution, 
they do not provide an answer to: Where do domains come from? However, the recent 
identification of repeats and internal symmetry within domains provide hints about the 
existence of a subset of building blocks smaller than the domains and it has been postulated 
that these units may have been combined to create domains from ‘scratch’. I will discuss 
some of the most prominent examples in the following section. 
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1.5. Domain definition and classification in SCOP 
 
The recognition of domains as structural building blocks is the basis of many protein 
classification methods such as the CATH Protein Structure Classification database (CATH) 
(Orengo et al. 1997), the Evolutionary Classification of Protein Domains (ECOD) (H. Cheng 
et al. 2014) and the Structural Classification Of Proteins (SCOP) (Murzin et al. 1995). In spite 
of their discrepancies in assignment, these classification methods agree upon that a domain 
constitutes an independently folding unit that can exist and evolve independently from the rest 
of the protein. A widely used compendium has been assessed by SCOP. Hereby proteins are 
divided into domains and each domain is sorted hierarchically into classes, folds, 
superfamilies, and families. Members of a given class are composed of the same secondary 
structural elements (SSE, e.g. all-ɑ and all-β), or their combinations (ɑ+β and ɑ/β). Domains 
displaying the same SSE, architecture and topological connections are categorized in the same 
fold. Finally, domains within the same fold are further classified in superfamilies and 
families, thereby sharing similar functionalities and a common origin. The classification of 
domains is possible, because despite the large number of theoretical shapes they can adopt, 
only an infinitesimal fraction are indeed represented. On the one hand, the number of particles 
in the known universe would not be enough to try all structural combinations (even for a 
relatively small domain of ~100 amino acids) (Alva et al. 2010). On the other hand, rules of 
physicochemical nature govern their amino acid interactions, in that manner, limiting the 3D-
structures they can adopt. Moreover, not all feasible structures are functional, therefore they 
would not pass the demanding selective functional pressure. Thus, it is not surprising that 
Nature has reused a set of optimized peptides as a good strategy to elaborate larger protein 
complexes. To date, SCOP recognizes 4919 superfamilies further sorted into 2026 families, 
which adopt only 1232 folds. Considering the much larger number of unique protein 
sequences on earth, this amount of shapes is still surprisingly small.   
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1.6. Difficulties in establishing domain boundaries 
 
In order to sort domains, it is necessary to establish their boundaries. However, this is not an 
easy task. One complication is the discontinuous distribution of a protein chain along two 
domains, which in fact accounts for 20% of these units (Orengo 2007). In addition, domains 
can vary in their topology connections, resulting from circular permutation, which can lead to 
disagreement in their classification by different methods. These and other issues such as 
decorations and deletions of short regions have as consequence that domain structures can 
vary to an extent that they are classified in different categories. For that reason, defining 
domain boundaries has been described as ‘an art more than a science’ and several 
classification methods have been described in the literature (Csaba, Birzele, and Zimmer 
2009; Day et al. 2003; Hadley and Jones 1999; Schaeffer et al. 2011: and Holland et al. 2006). 
For instance, in SCOP, Murzin and colleagues sorted domains mainly manually to give form 
to one of the most widely used databases. Manual classification has the advantage that it 
profits from the expertise of the protein scientists, however, it lacks the speed that is only 
offered by automated methods. Only recently, an automated algorithm was added to SCOP to 
assist the previously hand-curated database, creating the so called SCOPe database. 
Automated matches can be differentiated from the manual ones by the number zero placed at 
the end of their IDs. Other algorithms work entirely automated. Among them, CATH is one of 
the most commonly used (Orengo et al. 1997). SCOP and CATH converge to only 80% of 
their classified domains. Whereas CATH tends to break protein chains into smaller domains, 
SCOP keeps larger domains, leading to examples where a single domain in SCOP can be 
assigned to as many as six different smaller domains in CATH. To address this problem, 
studies suggest the usage of consensus sets (Day et al. 2003; Schaeffer et al. 2011). The 
advantage of employing such datasets is that they are useful to benchmark new methods for 
classifications but they lack the evolutionary knowledge included in SCOP.  
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1.7. Bioinformatic tools for the detection of remote homology  
 
To confirm common ancestry between proteins with low sequence similarity is a challenging 
task. Although it is generally accepted that over the time structure varies more than sequence, 
it is also known that similar structures can be the result of convergence (Goldstein 2008; Xia 
and Levitt 2004). Therefore, to confirm homology, sequence evidence is necessary. 
Occasionally, sequence similarity cannot be detected with standard methods such as Blast or 
PSI-Blast (Altschul 1997). However, the development of more sensitive methods such as 
Hidden Markov Models (HMMs)-based alignments have also made it possible to  detect 
homology between proteins with low sequence identity. This is because they profit from  
much more information than single sequence comparisons. In fact, HMMs store information 
of multiple sequences in a matrix, where the tendencies of mutations, deletions and extensions 
are calculated for each position of the aligned sequences to obtain a consensus profile that can 
be compared to other profiles. This method has been employed successfully in the past to 
detect homology among distantly related proteins and predict their previously unknown 
functions (Söding, Biegert, and Lupas 2005; Fidler et al. 2016; Bystroff and Krogh, n.d.). 
Another application of HMMs is the detection of subdomain related fragments among 
different folds. One example constitutes the flavodoxin-like, which shares an homologous 
fragment with other folds such as: (1) The TIM-barrel (Farías-Rico, Schmidt, and Höcker 
2014), (2) the periplasmic-binding protein-like I (Farias-Rico J., Toledo-Patino S., Götz S. & 
Höcker B., unpublished data), and as later described in this work, (3) the hemD-like fold. 
Interestingly, these evolutionary relationships are not isolated cases. In fact, an extended 
search among other fold categories yielded a large number of folds that share homology with 
many others (unpublished, Appendix 7.1). These examples not only illustrate evolutionary 
paths (Chapter 2) but also provide an alternative for the protein design, as I will discuss in 
Chapter 3. 
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1.8. Protein Design: a young but promising field   
 
The rational design of proteins is a young field. The first prototypes were built in the 70’s, by 
Gutte and colleagues, who developed a minimalistic version of the bovine ribonuclease. The 
resulting protein is half of the size of the original version and shows 16% of the native 
activity and a similar specificity. The same group engineered a DTT-binding protein and a 34-
residue peptide that was able to bind several trinucleotides and digest poly-C. These 
achievements were obtained via manual analysis of the amino acid composition and geometry 
of the desired structures. It was not until the late 90s that the first computational tools for 
protein design were developed and with them the first fully automated designs. In 1997 for 
instance, Mayo and colleagues designed a zinc finger protein with low sequence identity 
compared to known natural proteins (Dahiyat, Sarisky, and Mayo 1997) and shortly thereafter 
in 1998, Kim and coworkers developed a right-handed coil-coil, non-existent in Nature 
(Harbury et al. 1998). Baker et al, designed in 2003 the first protein with a fold not observed 
before in nature (Kuhlman et al. 2003) and in 2008 they implemented the unnatural Kemp 
elimination reaction onto a naturally occurring scaffold protein (Röthlisberger et al. 2008). 
Since then, advances in design algorithms have allowed the engineering of multiple novel 
functions and scaffolds, yet synthetic proteins are far from being able to compete with natural 
proteins in terms of speed and variety. Therefore, the development of new design approaches 
are desired.  
1.9. Combination of related fold fragments as an alternative for design 
 
The fact that Nature combines a limited set of units to create new architectures, inspired the 
development of a combinatorial approach for the design of proteins (Toledo-Patino S. (2013). 
“Design of chimeric proteins using homologous fragments from different folds” (Diploma 
thesis). Based on the premise that ‘if nature can do it, we can do it too”,  this work carries out 
the design of a fold-chimera that differs from the previously designed HisF-CheY fold-hybrid 
(Shanmugaratnam, Eisenbeis, and Höcker 2012), in that the fusion regions are selected based 
on sequence similarity in addition to their structural resemblance. A further hybrid design that 
employs this method is the PBP-CheY chimera (pdb: 4qwv, associated publication to be 
submitted), which contains fragments from the flavodoxin-like and the periplasmic-binding 
protein-like I folds. The successful combination of fragments raised the question, whether 
using this approach, a function could be transfer, which is one of the aims of this doctoral 
thesis and will be discussed in Chapter 4.   
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1.10. Aims and objectives 
 
This doctoral thesis contains three scientific projects that originated from my Master Studies. 
Inspired by the published evolutionary relationships between the TIM-barrel and flavodoxin-
like superfolds (Farías-Rico, Schmidt, and Höcker 2014) and perusing the hypothesis that 
domains are unlikely to have arisen independently, I dedicated my PhD to search for 
additional examples that support the assumption that different folds result from a subset of 
fragments. I designated the first part of my research to analyze sequence-based profile-profile 
alignments generated for the ɑ/β proteins based on the SCOP classification. The parsing of the 
data revealed that the majority of folds shared homologous regions with others. These 
findings brought me to the next question of my research, namely, whether these homologous 
fragments were selected during the course of evolution due to specific features, such as: 
stability or intrinsic plasticity that facilitated their combination. If that would be true, one 
should be able to combine these fragments, creating native-like fold-chimeras. We tested this 
hypothesis previously, creating a chimeric protein employing fragments from the flavodoxin-
like and the periplasmic-binding protein-like I fold. The hybrid protein expressed solubly and 
displayed resemblance to its parental proteins (Farias-Rico J., Toledo-Patino S., Götz S. & 
Höcker B., unpublished data). This result encouraged me to find a binding pocket within 
homologous fragments that could be transplanted into an acceptor fold in a similar manner.  
From an evolutionary point of view, the goal of this work consisted in selecting a pair of 
distant relatives to investigate their relationships in detail. I chose the hemD-like and 
flavodoxin-like folds, for which here I propose an emergence path (Chapter 2). From a 
design perspective, I employed their related fragments to transfer the vitamin B12 binding-
pocket from a cobalamin-binding domain (flavodoxin-like) into the uroporphyrinogen III 
synthase (hemD-like) (Chapter 3). The functional characterization of the resulting hybrid 
showed that it retained the transferred function (Chapter4).  
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Chapter 2 
The hemD-like fold encloses two flavodoxin-like fossils  
 
2.1. Overview 
 
A major evolutionary trigger constitutes domain duplication and divergence. In this process, 
the new copy is free to acquire a new function since the selective pressure is alleviated by the 
remaining copy. Usually, a duplicated domain retains a similar structure as the original 
template, even though their sequences diverge during the course of time. However, in a few 
cases, the duplicated domains fuse to create new scaffolds and continue to diverge to an 
extent where structural similarities to their single domain homologs are no longer evident. For 
that reason, proven cases of distant protein relatives that display low sequence similarities, 
different structures, and functions, are of great value and broaden our understanding on 
protein evolution.  
 
In this chapter, I will present the results of a profile-profile sequence analysis among ɑ/β 
proteins in SCOP, which yielded evidence to support the emergence of the hemD-like fold via 
insert-mediated segment-swapping and gene duplication of the ancient flavodoxin-like fold. 
To prove this hypothesis experimentally, I reverted these evolutionary events one by one, 
employing the intact C-terminal half of the hemD-like member, uroporphyrinogen III 
synthase (cU3S), and a variant lacking the insertion (cU3SΔ). The results were conclusive: 
cU3S builds multimers whereas cU3SΔ runs exclusively as monomer when subjected to an 
analytical gel filtration. Moreover, the NMR structure of cU3SΔ revealed the canonical 
flavodoxin-like architecture, strongly supporting a potential emergence path for hemD-like 
proteins. To the best of my knowledge, this is the first time an ancient fold is reconstructed 
employing the sequence of a different one without further mutations.   
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2.2 The uroporphyrinogen III synthase in a nutshell  
 
The uroporphyrinogen III synthase (U3S) is an essential enzyme found in all kingdoms of 
life. It catalyzes the conversion of hydroxymethylbilane (HMB) to uroporphyrinogen III (U3) 
(Figure 2.1), which is the last common precursor of all tetrapyrrole cofactors, the so-called 
pigments of life. These essential molecules are involved in metabolic and catalytic processes 
such as oxygen transport (hem), photosynthesis (chlorophyll), methane production (coenzyme 
F430) and methionine synthesis (cobalamins). In the absence of U3S, HMB spontaneously 
cyclize to generate non-physiological uroporphyrinogen I (UI) (Figure 2.1). In humans, this 
reaction is favored in cases of erythropoietic porphyria, a rare but severe disease that causes 
hypersensitivity to sun exposure due to U3S malfunction (Fortian et al. 2009).  
 
 
 
 
Figure 2.1 Synthesis of uroporphyrinogen I and III from hydroxymethylbilane. Spontaneous conversion of 
uroporphyrinogen I goes on non-enzymatically and has no physiological relevance, whereas conversion of its 
isomer uroporphyrinogen III requires the presence of uroporphyrinogen III synthase. Differences between the 
isomers are highlighted in red and yellow.  
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At a structural level, U3S is an ɑ/β bi-lobular enzyme that displays two distinct symmetry 
axes, which leads to disagreement in domain annotation by different systems. For instance, 
lobular symmetry is weighted by CATH Protein Structure Classification database (Dawson et 
al. 2017), which assigns U3S into two structural domains (Figure 2.2-A). This classification 
has three important implications: 1) it generates domains with different topologies, 2) one of 
these domains is discontinuous (contains both: N- and C-termini), and 3) the binding pocket 
located between the lobes, is disrupted. In contrast, the Structural Classification of Proteins 
(SCOP) (Murzin et al. 1995), considers U3S as a single domain enzyme, acknowledging the 
fact that the interface between the lobes is required for catalysis. U3S is the only member of 
the so called hemD-like SCOP superfamily and adopts the homonymous hemD-like fold 
(Figure 2.2-B). An alternative symmetry axis can be defined vertically, where the 
polypeptide chain is cut once in its middle to generate two antiparallel halves with the same 
amount of secondary structural elements and topological connections (Figure 2.2-C). Yet, 
none of the systems for domain classification considers these units as single domains, since 
this type of symmetry leads to disruption of the hydrophobic core of the protein, a premise 
widely accepted for domain definition. However, as I will discuss in the following section, in 
terms of evolution, this symmetry hides meaningful details about the emergence of the hemD-
like scaffold via gene duplication from a flavodoxin-like fold, a protein architecture that can 
be traced back to the last common ancestor of all kingdoms of life (Karlusich et al. 2014).  
 
 
 
Figure 2.2 Uroporphyrinogen III synthase (U3S) symmetry and domain assignment by CATH and SCOP. 
CATH dismantles U3S into two domains (A). In contrast, SCOP acknowledges U3S ligand binding and 
considers this enzyme as single domain (hemD-like fold) (B). Finally, antiparallel symmetry of U3S results from 
isolation of its N- and C-terminal halves (C). The above illustrated structures based on U3S structure from 
Thermus thermophilus pdb identifiers 3d8r and 3d8n. Uroporphyrinogen III (cognate ligand) is illustrate as 
spheres (gray).   
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2.3. Emergence of the HemD-like fold from flavodoxin-like fold gene 
duplication 
 
Evolutionary paths that led to the emergence of structural domains left a footprint in the 
sequences of contemporary proteins, which can only be uncover with the help of state-of-the-
art methods for remote homology detection. For instance, Hidden Markov Models (HMMs) 
are a powerful tool to detect distant homologs, since they enclose much more information 
than single-sequence comparisons. Recently, HMMs were employed to detect remote ancestry 
between the flavodoxin-like and TIM-barrel folds, which in spite of their overall different 
architectures, have been proposed to be related (Farías-Rico, Schmidt, and Höcker 2014). 
Inspired by these findings, we searched for further remote homologs within different fold 
categories, in particular among ɑ/β proteins, which are believed to enclose some of the oldest 
architectures (Taylor 2006). Thus, we generated HMMs for the ɑ/β-class of SCOP employing 
the HHsuite package (Söding 2005) and performed all-against-all sequence-based profile-
profile alignments without using the structural prediction part of the program1 (Methods 
6.1.1). The search revealed that the majority of the fold members shared homologous 
fragments of around 30 residues in length. However, a few spanned considerably larger 
regions in domain-sized ranges (Appendix 2). One of these exceptions represents the hemD-
like fold (circa 250 residues), which is hit twice by the flavodoxin-like fold (circa 115 
residues) at its N- and C-terminal halves, respectively. These observations not only suggested 
a duplication event but also indicated flavodoxin-like as the duplicating template (Figure 
2.3). Supporting this hypothesis, the N- and C-terminal halves of hemD-like also align to one 
another with probabilities nearly at 100%, clearly displaying their sequence similarity, which 
as expected corresponds also at a structural level. In contrast, the hemD-like halves do not 
superimpose with the flavodoxin-like structure. Whereas flavodoxin-like displays a globular 
architecture, the hemD-like halves present a segment-swap (Figure 2.4). This phenomenon 
has been previously studied by Szilágyi and colleagues with computational methods for 
molecular dynamics (Szilágyi, Györffy, and Závodszky 2017), proposing that the scaffold 
may have evolved via circular permutation of a mono-connected ancestor. However, in the 
following sections, I will provide sequence and experimental evidence that supports an 
alternative evolutionary scenario consisting of insertion, gene duplication and fusion.  
 
1 Profile-profile alignments were assessed by José Farías Rico  
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Figure 2.3 HemD-like fold emergence from flavodoxin-like. Profile-profile alignments showed that N- and C-
terminal hemD-like halves match each other and flavodoxin-like with probabilities above 90%, suggesting that 
HemD-like arose via flavodoxin-like gene duplication. Structural and topological discrepancies between the 
folds can be explained by an insert-mediated segment-swapping, which after fusion gave rise to the current bi-
lobular architecture of the uroporphyrinogen III synthase, which is the only enzyme known to adopt the hemD-
like scaffold.  
 
Figure 2.4 Structural discrepancies between flavodoxin-like fold and hemD-like halves. N- and C- terminal 
hemD-like halves correspond to each other in their topology and architecture (orange). However, they superpose 
only partially onto the flavodoxin-like fold (Figure 2.5-B), which displays a globular architecture (green). Pdb 
identifiers: 4es6 and 3whp, respectively.  
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2.4. An insertion in the flavodoxin-like fold mediated its transition to a bi-
lobular architecture 
 
When it comes to sustain homology, sequence identity is the most reliable source of 
information. However, at large evolutionary distances also similar structures or functions 
provide a solid hint for a common origin. In fact, even cases of proteins that display different 
functionalities, architectures and rather low sequence resemblance hide subtitle similarities in 
their sequence patterns. Thus, is it not surprising that scholars agree upon that convergent 
evolution is a rare phenomenon that accounts for only a small fraction of evolving proteins 
(Gough 2005; Forslund et al. 2008). While most evolutionary links are identified on the basis 
of sequence identity, the most fascinating discoveries resulted from searching in the so called 
‘twilight zone’. The hemD-like and the flavodoxin-like folds represent such an example of 
scaffolds that in spite of their overall differences, a handful of their members still retain 
sequence identity high enough to support a common origin. For instance, the C-terminal half 
of the uroporphyrinogen III synthase (U3S) from Pseudomonas aeruginosa (pdb: 4es6) 
matches the flavodoxin-like domain LitR from Thermus thermophilus (pdb: 3whp) with 30% 
sequence identity over 115 amino acids. These values are significant in terms of evolution 
according to a benchmarking published earlier (Sander and Schneider 1991). In this work, 
Sander and colleagues suggest that two sequences ≥ 80 amino acids in length can be 
considered homologous if they display at least 25.8% sequence identity. Thus, how is it 
possible that two sequences having high sequence similarity display different architectures? If 
we have a closer look at the U3S and LitR topologies, it becomes obvious that they share the 
same secondary structural elements (SSE) except by an insertion of six amino acids that form 
a beta strand (Figure 2.5). Moreover, their SSE have the same order, differing only in their 
orientation in space due to an ɑβα-swap. Interestingly, but perhaps not surprisingly, the 
predicted insertion is located right before the swapped elements in all hemD-like halves but in 
any of the flavodoxin-like members. These observations brought me to the conclusion that the 
insert may have mediated the swapping, parting from a flavodoxin-like precursor. If this was 
the case, truncation of one hemD-like half and removal of its insertion should lead to the 
reconstruction of a protein with a flavodoxin-like topology and architecture. Therefore, I 
employed the U3S C-terminal half from P. aeruginosa to revert in vitro the events that 
potentially led to the emergence of the hemD-like scaffold. I will review the obtained 
experimental results in the following sections. 
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A) 
 
B) 
 
Figure 2.5 Sequence and structural alignment for the best-scored HHsearch hit. The best ranked sequence-
based profile alignment, according to sequence identity, constitutes the C-terminal half of the uroporphyrinogen 
III synthase (U3S) from Pseudomonas aeruginosa (pdb: 4es6) towards the quorum sensing transcriptional 
regulator (LitR) from Thermus thermophilus (pdb: 3whp). Secondary structural elements are highlighted in 
orange and green for U3S and LitR, respectively. The insertion forming a beta strand is shown in black. The 
values obtained by HHsearch are: 30% sequence identity, 88% probability and E-value = 0.11 over 105 residues 
(A). Alignment of the U3S C-terminal half on the LitR structure reveals an ɑβɑ-segment-swap in U3S in respect 
to LitR, which adopts the globular architecture characteristic of flavodoxin-like members.  
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2.5. Experimental Reconstruction of flavodoxin-like from one hemD-like half 
 
To reverse the gene duplication and insertion events experimentally, two different constructs 
were generated: 1) the intact C-terminal half of the uroporphyrinogen III synthase (cU3S) 
from Pseudomonas aeruginosa (residues H129 to A251), and 2) a derived variant (cU3SΔ) 
lacking the predicted insertion, which builds a beta strand with residues Y162 to P167 
(Figure 2.6-A). As template, the PA5259 plasmid was employed, which has been described 
elsewhere (Schnell and Schneider 2013) and was kindly handed out by Prof. Gunter 
Schneider and Dr. Robert Schnell. cU3S and cU3SΔ were amplified by PCR (Section 6.2.1) 
and cloned into a pET21a vector system, yielding the constructs pET21a-cU3S and pET21a-
cU3SΔ, whose sequences were validated at the sequencing facility of the Max Planck Institute 
in Tübingen. Protein expression for both constructs showed soluble expression. However, 
cU3S expressed mainly in the inclusion bodies compared to cU3SΔ (Figure 2.7-A). In 
addition, native cU3S was less stable and aggregated already at a concentration of 1 mg/ml, 
precipitating gradually during the purification process (Figure 2.7-B), whereas cU3SΔ 
remained stable at concentrations above 25 mg/ml, running exclusively as monomer when 
loaded onto a gel filtration column (Figure 2.7-C). In an attempt to obtain better yields of 
soluble protein, cU3S was refolded with guanidinium chloride (Section 6.13). However, it 
aggregated, forming multimers of diverse sizes, indicating its tendency to associate with other 
halves, whereas the deleted variant stayed as monomer even after refolding under the same 
conditions. The CD spectra for both constructs showed well-folded proteins with very similar 
ɑβ-content (Figure 2.7-D). However, the thermal denaturation indicated a lower thermal 
stability for cU3S (Tm=45℃) compared to cU3SΔ (60℃) (Figure 2.7-E). None of the 
variants crystallized in any of the screenings attempted (Section 5.2.6). However, the stability 
of cU3SΔ at high concentration and temperature made it possible to elucidate its NMR 
structure2, which revealed the successful reconstruction of a compact monomeric architecture 
(Figure 2.6-A). The cU3SΔ structure clearly displays a flavodoxin-like topology and 
architecture. However, by definition, two domains belong to the same fold if their structures 
align with an RMSD ⋜ 3Å. Therefore, I performed a  structural alignment with cU3SΔ 
against the PDB90, employing the server for protein structure comparison DALI (Holm and 
Laakso 2016). The results corroborated that cU3SΔ adopts a flavodoxin-like fold, as it 
matches flavodoxin-like members with RMSD values down to 2.7Å (Table 2.1). As expected, 
 
2 NMR structure (unpublished) was solved by Murray Coles and Manish Chaubey at the Max Planck Institute in 
Tübingen, Germany. 
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cU3SΔ also hits its parental protein and other hemD-like members, showing RMSD values of 
2.2Å and up to 2.5Å, respectively (Table 2.1). Moreover, a closer look to the cU3SΔ 
structure, revealed residue-residue interactions at the interface created between the originally-
swapped region with the accepting fragment (Figure 2.6-B). These interactions promote the 
formation of a hydrophobic core.  
 
A) 
 
B) 
 
Figure 2.6 experimental reconstruction of flavodoxin-like from the hemD-like C-terminal half. The N-
terminal half of uroporphyrinogen III synthase (U3S, orange, pdb: 4es6) from Pseudomonas aeruginosa was 
removed, leading to an unstable truncated C-terminal half (in brackets). After removing the insert (black) 
predicted by sequence-based profiles alignments, the resulting protein adopted the flavodoxin-like fold, whose 
structure was successfully solved by nuclear magnetic resonance (green) (A). cU3SΔ NMR structure shows the 
originally swapped ɑβɑ-segment (cartoon) successfully flipped back, rebuilding residue-residue contacts with 
the accepting fragment (ribbon) (B).   
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Figure 2.7 Biophysical characterization of hemD-like half variants.  The characteristic white color that 
results from recombinant expression in the inclusion bodies was particularly observed for cU3S in contrast to the 
cU3SΔ crude extract (A). Soluble expression of cU3S showed gradual protein precipitation during the 
purification process (B). At low concentration, cU3S (black dashed line) remained as a monomer when loaded 
onto a gel filtration, whereas cU3SΔ (orange solid line) remained as monomer even at concentrations above 25 
mg/ml (C). CD signal showed similar secondary structural elements for both variants (D) however, the thermal 
denaturation indicated a higher stability for the deleted version (E).   
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Table 2.1 Structural alignment of cU3SΔ against the PDB90 employing DALI structure library. The NMR 
structure matches its parental U3S (lower lobe) at 2.2Å and 14 Z score (orange). Proteins adopting a flavodoxin-
like architecture are also hit with RMSDs up to 2.7Å and Z scores up to 11.2 (green).  
__________________________________________________________________________________________ 
Rank   pdb    Z     RMSD L     nres  ID   Description 
   1:  4es6-A 14.0  2.2  111   249   70   UROPORPHYRINOGEN-III SYNTHASE;                                
   2:  3re1-B 13.8  2.5  116   257   48   UROPORPHYRINOGEN-III SYNTHETASE;                            
   3:  3mw8-A 11.7  2.5  110   237   28   UROPORPHYRINOGEN-III SYNTHASE;                              
   4:  1wd7-B 11.3  2.7  117   255   14   UROPORPHYRINOGEN III SYNTHASE;                              
   5:  2j48-A 11.2  3.1  109   119   13   TWO-COMPONENT SENSOR KINASE;                                
   6:  1jr2-A 10.9  3.0  111   260   17   UROPORPHYRINOGEN-III SYNTHASE;                              
   7:  4qpj-D 10.7  2.7  112   121   13   PHOSPHOTRANSFERASE;                                         
   8:  1xhe-B 10.3  2.7  109   122   15   AEROBIC RESPIRATION CONTROL PROTEIN ARCA;                   
   9:  2zwm-A 10.1  2.9  111   120   17   TRANSCRIPTIONAL REGULATORY PROTEIN YYCF;                    
  10:  4lda-B  9.9  3.5  117   128   18   TADZ;                                                       
  11:  3ilh-A  9.9  2.8  114   133   11   TWO COMPONENT RESPONSE REGULATOR;                           
  12:  2qr3-A  9.8  2.9  110   121   15   TWO-COMPONENT SYSTEM RESPONSE REGULATOR;                    
  13:  6br7-B  9.8  3.2  113   125   17   TWO-COMPONENT SYSTEM RESPONSE REGULATOR PROTEIN;            
  14:  2zay-A  9.8  3.2  113   123    9   RESPONSE REGULATOR RECEIVER PROTEIN;                        
  15:  3jte-A  9.8  3.3  113   126   12   RESPONSE REGULATOR RECEIVER PROTEIN;                        
  16:  3t6k-A  9.8  3.2  111   122   18   RESPONSE REGULATOR RECEIVER;                                
  17:  5u8k-B  9.7  3.5  113   230   11   RESPONSE REGULATOR;                                         
  18:  5m7o-A  9.7  3.2  115   448   17   NITROGEN ASSIMILATION REGULATORY PROTEIN;                   
  19:  1k7y-A  9.7  2.8  113   577   12   METHIONINE SYNTHASE;                                        
  20:  5xt2-B  9.7  3.0  110   204   16   RESPONSE REGULATOR FIXJ;                                    
  21:  3grc-A  9.7  3.1  111   125   16   SENSOR PROTEIN, KINASE;                                     
  22:  5m7n-B  9.7  3.4  113   428   18   NITROGEN ASSIMILATION REGULATORY PROTEIN;                   
  23:  3dge-C  9.6  3.1  110   122   18   SENSOR PROTEIN;                                             
  24:  1y80-A  9.6  2.7  104   125   16   PREDICTED COBALAMIN BINDING PROTEIN;                        
  25:  5wq0-D  9.6  3.1  113   129   15   STAGE 0 SPORULATION PROTEIN;                                
  26:  4nic-A  9.6  2.7  105   117   14   DNA-BINDING TRANSCRIPTIONAL REGULATOR RSTA;                 
  27:  1dc7-A  9.5  2.9  109   124   17   NITROGEN REGULATION PROTEIN;                                
  28:  4jgi-B  9.5  2.7  104   206   11   PUTATIVE UNCHARACTERIZED PROTEIN;                           
  29:  4s04-A  9.5  3.0  111   219   12   DNA-BINDING TRANSCRIPTIONAL REGULATOR BASR;                 
  30:  5ep0-A  9.5  3.1  112   380   13   PUTATIVE REPRESSOR PROTEIN LUXO;                            
  31:  1ys6-B  9.4  3.2  112   227   15   TRANSCRIPTIONAL REGULATORY PROTEIN PRRA;                    
  32:  4q7e-A  9.4  3.2  111   125   19   RESPONSE REGULATOR OF A TWO COMPONENT REGULATORY            
  33:  3m6m-D  9.3  3.0  105   118   16   RPFF PROTEIN;                                               
  34:  2gwr-A  9.3  3.3  109   225   16   DNA-BINDING RESPONSE REGULATOR MTRA;                        
  35:  2qzj-A  9.3  3.1  108   121   14   TWO-COMPONENT RESPONSE REGULATOR;                           
  36:  4h60-A  9.3  3.2  109   120   16   CHEMOTAXIS PROTEIN CHEY;                                    
  37:  4uhk-A  9.3  3.5  113   130   14   TRANSCRIPTIONAL REGULATORY PROTEIN CPXR;                    
  38:  4l4u-A  9.3  3.3  113   388   16   TRANSCRIPTIONAL REGULATOR (NTRC FAMILY);                    
  39:  2qv0-A  9.2  3.0  106   122   16   PROTEIN MRKE;                                               
  40:  2nt4-A  9.2  3.1  107   126   19   RESPONSE REGULATOR HOMOLOG;                                 
  41:  3q9s-A  9.2  3.2  113   210   17   DNA-BINDING RESPONSE REGULATOR;                             
  42:  3cfy-A  9.2  3.7  115   130   10   PUTATIVE LUXO REPRESSOR PROTEIN;                            
  43:  5dcl-A  9.2  2.9  108   117   15   PHOB FAMILY TRANSCRIPTIONAL REGULATOR;                      
  44:  2rjn-A  9.2  3.8  114   135   12   RESPONSE REGULATOR RECEIVER:METAL-DEPENDENT                 
  45:  3luf-B  9.1  2.8  111   246   14   TWO-COMPONENT SYSTEM RESPONSE REGULATOR/GGDEF               
  46:  3hdv-B  9.1  3.0  107   126   19   RESPONSE REGULATOR;                                         
  47:  2jba-A  9.1  3.3  111   125   14   PHOSPHATE REGULON TRANSCRIPTIONAL REGULATORY PROT           
  48:  1nxp-A  9.1  2.8  105   118   17   DNA-BINDING RESPONSE REGULATOR;                             
  49:  1sqs-A  9.0  2.9  116   232   10   CONSERVED HYPOTHETICAL PROTEIN;                             
  50:  1zgz-A  9.0  2.9  104   121   11   TORCAD OPERON TRANSCRIPTIONAL REGULATORY PROTEIN 
 
Abbreviations: Z-score (Z), alignment length (L), total number of residues (nres) and  sequence identity (ID)    
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2.6.  Segment-swaps and their role in the evolution of new folds 
 
While three-dimensional domain swapping has been widely described in the literature 
(Bennett, Choe, and Eisenberg 1994; Bennett, Schlunegger, and Eisenberg 1995; Gronenborn 
2009; Jaskólski 2001; Liu and Eisenberg 2002), only little attention has been paid to segment-
swaps (SSPs) (Andreeva and Murzin 2006; Szilágyi, Zhang, and Závodszky 2012). In this 
process, only a few structural elements within a domain are flipped, creating residue-residue 
contacts with a complementary protein fragment. It has been estimated that at least 18 
structural families present well-defined covalently linked swapped regions (Szilágyi, Zhang, 
and Závodszky 2012). However, SSPs are also observed as crystallization artifacts (Farías-
Rico, Schmidt, and Höcker 2014), oligomerization of engineered proteins (Riechmann et al. 
2005)  and more interestingly, as dynamic transitions required for natural functions. One 
example constitutes the Glyoxilase I, which is assembled of two non-covalently linked 
domains that dislocate to build a functional protein (Cameron 1997). Interestingly, the 
dihydroxybiphenyl dioxygenase displays a similar architecture, however it lacks the SSP and 
its building units are embedded in a single chain. Scholars suggest that these two proteins are 
related based on their similar metal-binding positions and structures (2Å over 79 Cɑ atoms), 
suggesting that the SSP may have led to the different function in Glyoxylase I (Cameron 
1997). Thus, SSPs illustrate the plastic nature of proteins to adopt alternative conformations. 
This is a successful strategy to reach complexity and size by joining fragments that do not 
require to be covalently attached. They provide new cavities for binding and motion restrains 
for catalysis, particularly if the involved units become fused in a single chain. This appears to 
be the case for the uroporphyrinogen III synthase (U3S), in which the insert-mediated SSP 
provided the necessary extension to create a cleft for binding and the interdomain linkers 
conferred movement restriction, perhaps improving catalysis. Previously, the impact of 
flexibility restriction on the U3S lobes has been studied (Szilágyi, Györffy, and Závodszky 
2017). In this work, Szilágyi and colleagues simulated the conversion of U3S into a mono-
connected bi-lobular enzyme by circular permutation (in silico), observing a considerable 
decrease in its reaction capacity. Based on these results, Szilágyi and colleagues suggest that 
circular permutation was a step in the U3S emergence path, which conferred it an 
evolutionary advantage over a hypothetical mono-connected scaffold due to improvements in 
entropy costs, thus achieving lower free energies for binding. I will discuss this potential 
scenario in the following section. 
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2.7.  Circular permutation as potential emergence path for hemD-like 
 
Circular permutations (CPs) are rare events, accounting for only 5% of proteins with known 
structure (Jung and Lee 2001). While CPs are easily visualized at a structural level, this 
process is less straightforward at a genetic level and several mechanisms have been proposed 
to explain their formation (Vogel and Morea 2006).  As pointed out in the previous section, a 
circular permutation event has been proposed for the emergence of uroporphyrinogen III 
synthase (U3S). To test this hypothesis, I assessed an HHsearch employing a database of 
manually permuted U3S halves (Section 5.4.1 and 6.1.4) to search for high sequence 
identities towards flavodoxin-like proteins contained in the SCOP and pdb databases. The 
results showed that the permuted variants not only scored flavodoxin-like with lower 
probabilities than their intact halves (Table 2.2), but in addition none of the hits showed a 
statistically significant sequence identity towards flavodoxin-like members. These 
observations, speak in favor of the insertion-mediated segment-swapping and correlate with 
the fact that permutation is less common than domain duplication, which is the most common 
event in domain evolution (Lupas, Ponting, and Russell 2001; Chothia and Gough 2009). 
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Table 2.2 Best-ranked HHsearch hits for hemD-like halves and their circular-permuted variants.  
Q ID S ID Function CATH SCOP P SI Cols Qs Qe Ss Se 
4es6_ct 3whp_A Cobalamin-binding  3.40.50.280 c.23.1 88 30 105 2 119 169 279 
3re1_ct 4hh0_A Cobalamin-binding  3.40.50.280 c.23.1 90 24 117 1 128 271 402 
3re1_ct d1yioa2 Response regulator 3.40.50.2300 c.23.1 91 24 108 3 124 3 119 
3re1_ct 3whp_A Cobalamin-binding  3.40.50.280 c.23.6 91 23 110 1 123 168 285 
4es6_ct 4r3u_C Cobalamin-binding  3.40.50.280 c.23.6 94 23 114 1 121 15 139 
4es6_ct 4hh3_C Cobalamin-binding  3.40.50.280 c.23.6 91 23 115 1 123 105 234 
d8r_L1 3ph3_A Ribose-5P isomerase 3.40.1400.10 c.121 87 21 118 1 126 21 143 
3d8r_L1 d3he8a_ Ribose-5P-isomerase 3.40.1400.10 c.121 95 21 118 1 126 1 123 
3mw8_ct d1ccwa_ Cobalamin-binding  3.40.50.280 c.23.6 96 21 110 3 119 5 130 
3mw8_ct d1u0sy_ Response regulator 3.40.50.2300 c.23.1 94 21 103 1 120 1 115 
3mw8_ct d2zwma_ Response regulator 3.40.50.2300 c.23.1 91 21 101 2 119 2 112 
3mw8_L2 d1ccwa_ Cobalamin-binding  3.40.50.280 c.23.6 90 21 110 84 199 2 127 
3re1_ct 5c8a_A Cobalamin-binding  3.40.50.280 c.23.6 90 21 112 1 124 84 202 
3re1_ct d1fmfa_ Cobalamin-binding  3.40.50.280 c.23.6 95 21 102 13 123 19 134 
4es6_L1 4r3u_C Cobalamin-binding  3.40.50.280 c.23.6 92 21 114 2 123 15 139 
3d8r_nt d1dxya2 HI-dehydrogenase 3.40.50.720 c.23.12 94 20 104 1 117 1 107 
3mw8_ct d2jbaa_ Response regulator 3.40.50.2300 c.23.1 92 20 106 2 119 2 115 
3re1_ct 4r3u_C Cobalamin-binding  3.40.50.280 c.23.6 94 20 114 1 121 15 139 
3re1_ct d3to5a_ Response regulator 3.40.50.2300 c.23.1 89 20 112 2 124 4 124 
3re1_ct d1ys7a2 Response regulator 3.40.50.2300 c.23.1 89 20 107 4 123 3 117 
3re1_ct d3hdva_ Response regulator 3.40.50.2300 c.23.1 86 20 110 4 124 3 120 
3re1_ct d1zh2a1 Response regulator 3.40.50.2300 c.23.1 85 20 106 4 123 2 115 
4es6_ct d3q15c_ Response regulator 3.40.50.2300 c.23.1 94 20 106 3 122 1 115 
4es6_L1 d1ccwa_ Cobalamin-binding  3.40.50.280 c.23.6 96 20 115 1 123 1 132 
4es6_L1 d1xrsb1 Cobalamin-binding  3.40.50.280 c.23.6 88 20 102 14 123 35 153 
 
Abbreviations: Q ID: query ID, S ID: subject ID, P: probability, SI: sequence identity in percent, Cols: number of aligned residues 
(columns) in sequence profile Qs: residue where the query alignment starts, Qe: residue where the query alignment ends, Ss: residue where 
the subject alignment starts, Se: residue where the subject alignment ends, ct: C-terminus, nt: N-terminusl, L1: lower U3S lobe (circular 
permutation), and L2: upper U3S lobe (circular permutation). 
 
Query (hemD-like) IDs: 4es6: Pseudomonas aeruginosa, 3re1: Pseudomonas syringae, 3mw8: Shewanella amazonensis, 3d8r: Thermus 
thermophilus. 
Subject  IDs: 3whp:  Thermus thermophilus, d1yioa2: Pseudomonas fluorescens, 4r3u_C: Aquincola tertiaricarbonis, 4hh3_C: 
Rhodobacter phaeroides, d1ccw_A (1ccw_A): Clostridium cochlearium, d1s8na_: Mycobacterium tuberculosis, 5c8a_A: Thermus 
thermophilus  d2zwma_: Bacillus subtilis,  d1fmfa_: Clostridium tetanomorphum, d2jbaa_: Escherichia coli, d3to5a_: Vibrio cholerae, 
d1ys7a2: Mycobacterium tuberculosis, d3hdva_: Pseudomonas putida,  d1zh2a1: Escherichia coli, d3nhma_: Myxococcus xanthus  
d2v0na2:  Caulobacter vibrioides, d3q15c_: Bacillus subtilis,  d1dxya2: Lactobacillus paracasei.  
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2.8. HemD-like and periplasmic-binding protein like-I share a common origin 
 
Another fold that shows a clear relationship to hemD-like constitutes the periplasmic-binding 
protein-like (PBP, SCOP ID c.93). This fold is particularly interesting because it aligns nearly 
all amino acids in hemD-like fold with probabilities up 93%. The sequence identities between 
the lobes are rather low (up to 17%), but their architectures and topologies are remarkably 
similar. In addition, hemD-like and PBPs share similar features such as a bi-lobular 
architecture and a binding site between their lobes (Figure 2.8-A to B). Initially, I 
hypothesized that one may have derived from the other. For instance, via circular 
permutation. However, the profile-profile alignments revealed that flavodoxin-like also hits 
PBP-I twice at its N- and C-terminal halves with sequence identities up to 27%. This suggests 
that in analogy to hemD-like, PBP-I may have evolved from flavodoxin-like gene duplication. 
Interestingly, a truncated half of a PBP-I member, the ribose-binding protein (RBP) from 
Thermotoga maritima, expresses in situ as a side product of its recombinant expression in 
Escherichia coli (Cuneo, Beese, and Hellinga 2008). At the DNA level, the RBP sequence 
bares a ribosomal-binding site at about the half of the gene, which can be recognized by E. 
coli. The resulting protein is about the half of the size of the full-length RBP protein, is 
soluble and thermostable, sustaining the hypothesis of a flavodoxin-like precursor. In fact, 
previous researches have pointed out the possibility of gene duplication for the emergence of 
PBPs (Fukami-Kobayashi et al. 1999).  Thus, how is it possible that two folds that originated 
from duplication of the same protein display different topologies? Circular permutation may 
be the immediate or intuitive answer. However, the topological discrepancies between PBP 
and hemD-like can be additionally described as the result of an alternative flavodoxin-like 
segment-swap, namely a C-terminal alpha helix instead of the N-terminal αβα-element in 
hemD-like (Figure 2.8-C). However, whether there are additional steps missing, remains to 
be investigated.  
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Figure 2.8 Evolutionary implications of segment-swapping. The case of the flavodoxin-like fold. Profile-
profile comparisons suggest that hemD-like (orange) and periplasmic-binding protein-like I (PBP, purple) folds 
evolved via flavodoxin-like (green) gene duplication (A). HemD-like and PBP display a distinct topology but a 
similar architecture and both bind their cognate ligands (gray) between their protein lobes (B). Structural 
alignments of the flavodoxin-like fold vs. hemD-like and PBP halves reveal an N-terminal and C-terminal 
segment-swap, respectively, which appear to cause their different topological connections (C).  
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2.9. Discussion 
 
Here we extend our initial search for homology links across domain boundaries (Section 1.9) 
by exploring a particular case of insert-mediated segment-swapping and gene duplication of a 
flavodoxin-like ancestor that lead to the hemD-like scaffold. 
The sequence and structural resemblance between the hemD-like N- and C-terminal halves, 
suggest that they resulted through gene duplication (Section 2.3). Consolidating this 
hypothesis, the sequence alignment between the flavodoxin-like member LitR3 and the C-
terminal half of U3S4 provides with statistically significant evidence that supports the 
flavodoxin-like fold is the duplicated precursor (Section 2.4). Finally, the extraction of an 
insertion presented only in the hemD-like halves, revealed the successful reconstruction of the 
canonical flavodoxin-like topology (Section 2.5).  
Based on the gathered results, I suggest that a flavodoxin-like ancestor may have undergone 
an insertion that mediated a segment-swap. This domain dislocation facilitated the association 
of two units, leading to the hemD-like bi-lobular architecture. Similar phenomena have been 
observed as likely artifacts for other flavodoxin-like proteins (pdb identifiers: 4q375 and 
3c85) but also playing a role in catalysis in natural enzymes (Section 2.6). U3S may have 
acted in a similar fashion. First the insertion may have mediated better association conditions. 
Finally, fusion contributed with motion restrains to lower the entropy costs for binding.  
Overall, these results illustrate that evolutionary events can be reconstructed experimentally 
similar to the reconstruction of TIM-barrels from their halves (Höcker, Claren, and Sterner 
2004). This time, however, the reconstruction of an ancestral superfold has been assessed, 
employing the sequence of a different fold, displaying the plastic nature of proteins and 
highlighting that segment-swaps presumably played a greater role in evolution than assumed 
before.   
 
 
 
  
 
3 Quorum sensing transcriptional regulator (LitR) from Thermus thermophilus (pdb: 3whp) 
4 Uroporphyrinogen III synthase (U3S) from Pseudomonas aeruginosa  (pdb: 4es6) 
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Chapter 3 
Design of a cobalamin-binding fold-chimera 
 
3.1 Overview 
 
Despite the advances in developing methods for protein design, since the first attempts back in the 70s, 
humans still cannot compete with Nature in creating highly efficient catalysts. Significant 
contributions to the field have been achieved through the use of directed evolution (Arnold 2015; 
Goldsmith and Tawfik 2012). The success of this method is based on mimicking the natural 
phenomenon of introducing mutations at random, with the eventual result of improving a protein 
feature. One limitation, however, is that novel functions will be hardly explored by this approach, 
since the high throughput selection methods that are usually coupled to it, require previous knowledge 
of the feature to be selected. This issue is partially addressed by de novo design, which probes 
sequence combinations beyond the ones explored by Nature. Nevertheless, this method also has its 
limitations. For instance, only a fraction of protein designs adopts stable folded structures when 
recombinantly expressed in E. coli. Insolubility and polydispersity are  the most common reasons for 
failure, which most likely arise due to unanticipated hydrophobic interactions (Huang, Boyken, and 
Baker 2016; Khoury et al. 2014).  
Here we pursue the long-standing goal of complex custom-made protein design, addressing some of 
the limitations of de novo design such as foldability by combining homologous fragments. These 
fragments appear to be a good source for well-folded and solubly-expressed protein chimeras (Höcker 
2014). In addition, we address the question, whether pre-existing cofactor or binding pockets can be 
placed in different contexts from the ones observed for naturally-occurring enzymes, with the long-
term goal of employing these cofactors to assist novel functionalities.  
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3.2. Searching for cofactor-binding pockets within homologous fragments 
 
Hidden Markov Models were employed previously to find homologous regions within ɑ/β 
proteins (Chapter 1.9). The gathered results yielded a large number of fragments shared by 
different folds (Appendix 1-2). However, from the obtained fragments, only a small fraction 
is large enough to bare whole cofactor-binding pockets for our design purposes. One example 
of a protein pair that shares large homologous regions constitute the flavodoxin-like and 
hemD-like folds (Figure 2.3). As discussed in Chapter 2, their sequence and structural 
resemblance strongly suggest that a flavodoxin-like fold duplication gave rise to the 
uroporphyrinogen III synthase (U3S). This is advantageous for our strategy, since it can be 
assumed that practically the whole hemD-like architecture is related to the flavodoxin-like 
one, meaning that any desired fragment can be replaced by its corresponding region from the 
other. Therefore, we looked for interesting functions among the 16 flavodoxin-like SCOP 
families, and identified the cobalamin-binding domain as a suitable target for design. 
 
3.3. Functional considerations for the selection of parental proteins 
 
Before proceeding to design the chimeric protein, a number of considerations were taken into 
account. Special attention was paid to the fact that members of the cobalamin-binding family 
only trap the sugar moiety of vitamin B12 derivatives (Martin Tollinger et al. 2001) whereas 
the β-axial (upper) face of the cofactor is usually protected by a second domain, which varies 
according to the enzymatic function (Figure 3.1). For instance, the methylmalonyl-CoA and 
glutamate mutases act with the help of a TIM-barrel counterpart, whereas both: The O-
demethylase and methionine synthase require a four-helix bundle. To date, there is no 
structure of a cobalamin-binding domain bound to cobalamin in absence of a protecting 
domain, which may be an indication that a shielding protein is required to keep cobalamin in 
place. To fulfill these requirements in our design, we anticipated that the upper lobe in U3S 
could act as domain counterpart (Figure 3.2), whose large inner interface towards the binding 
region could be advantageous to introduce further mutations for design. In addition, the U3S 
scaffold displays a large cavity that provides enough space to accommodate the bulky 
cobalamin, once the binding pocket is transplanted (Figure 3.2).  
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Figure 3.1 Cobalamin-binding domain and interacting partners.  The structures illustrated above correspond 
to four cobalamin-dependent enzymes, whose cofactor-binding domain is shown in green, domain counterparts 
in gray and the bound cofactor in black. From left to right are displayed: glutamate mutase (pdb: 1ccw), 
methylmalonyl-CoA mutase (pdb: 7req), methionine synthase (pdb:1bmt) and O-demethylase (pdb: 4jgi). Even 
though the last example appears not to shield cobalamin with the helper domain, in the crystal structure the 
cofactor is covered by the helical bundle domain from a vicinal protein. These examples show that protecting the 
cofactor from solvent may be necessary for keeping it in place or for proper function.  
 
 
 
 
 
Figure 3.2 Functional considerations for hybrid design. The upper lobe of U3S provides a shield for the 
ligand from solvent as well as a large inner interface for further design mutations (1). In addition, the cleft 
between its lobes provides enough space (2) to accommodate the bulky cobalamin (3), which is shielded by a 
domain counterpart in all cobalamin-dependent enzymes (4). Pdb identifiers: 1jr2 (orange) and 1req (green-
gray). 
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Only a handful of uroporphyrinogen III synthase structures have been solved. Nevertheless, 
there are enough of them to illustrate the wide range of relative domain orientations their 
protein lobes can adopt. The structures display aperture differences of their lobes of up to 23.6 
Å and rotations up to 90° from one structure to another (Schubert et al. 2008). We selected the 
human ortholog over the others, because it displays the largest opening between its lobes. 
This characteristic was highly desired, since a large opening may facilitate accommodation of 
a cobalamin molecule without encountering steric problems (Figure 3.3). Another crucial 
aspect to consider for the chimeric design is undoubtedly the sequence and structure 
similarity. We selected the methylmalonyl-CoA mutase from Aeropyrum pernix as cofactor 
donor, since it showed the highest sequence identity (23%) to the human U3S and high 
structural resemblance (Figure 3.3). In addition, this protein has been solved as a single 
domain and comes from a highly thermostable organism, which are both properties that we 
considered advantageous for design, as not all domains are stable when they are isolated from 
their counterparts.  
 
 
Figure 3.3 Structure alignment of selected parental proteins. The structure of the cobalamin-binding domain 
(green) of methylmalonyl-CoA mutase (MCoAM) from Aeropyrum pernix (pdb: 2yxb) superimposed onto the 
lower lobe of the human uroporphyrinogen III synthase (orange, pdb: 1jr2:A) shows high structural resemblance. 
The cobalamin molecule has been placed via structural alignment of the crystal structure of the MCoAM of 
Propionibacterium freudenreichii (pdb: 1req) superposed to the apo structure of MCoAM from Aeropyrum 
pernix (pdb: 2yxb) to illustrate that U3S confers enough space for placing cobalamin (black).    
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3.4. Fold-chimeragenesis 
 
To define the chimeric crossovers, we searched for well-superposed areas, ideally containing 
similar residues. In addition, we aimed to cut in the middle of secondary structural elements 
instead of loops to build hybrid secondary structural elements. First, the N-terminal cut site 
was chosen where the residues at the desired transition were very similar and the 
corresponding structures well-aligned (Figure 3.4). Thus, we truncated the sequence of 
methylmalonyl-CoA mutase (MCoAM) at residue V52, joining the sequence of 
uroporphyrinogen III synthase (U3S) starting with L32, building a chimeric beta strand. The 
C-terminal crossover, however, was a bit more challenging due to an insertion of one amino 
acid in the sequence of U3S. This residue changes slightly the register of the helix in respect 
to the flavodoxin-like fold and its distance to the protein core (Figure 3.4). As a consequence, 
the sequence-based profile-alignment does not correspond to the structural one. For that 
reason, we looked for similar residues to build the transition, finding that we could replace 
L180 of U3S by V63 of MCoAM. The resulting chimeric sequence and protein model are 
shown in Figure 3.5. 
 
Figure 3.4 Selection of chimeric crossovers.  The N-terminal crossover was performed according to the 
sequence alignment by HHsearch, replacing U3S-T31 by MCoAM-V52, which correspond also at a structural 
level (A-left). In contrast, the sequence alignment by HHsearch (A-right) differs from the structural alignment 
(B). Whereas MCoAM-V63 aligns in sequence with U3S-N181 (yellow), it aligns structurally with U3S-L180. 
This discrepancy is owed to an insertion in the U3S sequence, which causes a change in the helix register by one 
amino acid. Therefore, we followed the structural alignment, replacing U3S-L180 by MCoAM-V63.  
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Figure 3.5 Chimeric design and hybrid model. Chimeric protein sequence (A), model (B) and topological 
connections (C). Crossovers are shown in red and cobalamin has been placed, superimposing the cobalamin 
from methylmalonyl-CoA mutase from Propionibacterium freudenreichii (pdb: 1req).  
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3.5. Cloning, protein expression and purification 
 
The chimeric gene was assembled by PCR employing two fragments from MCoAM and one 
fragment from U3S, all fragments contained overlapping regions to facilitate annealing 
(Figure 3.6). The MCoAM fragments were amplified from the construct 
13AN6UP_MMcM_pMA purchased from Life Technologies (Section 5.5.1). The U3S region 
was amplified from template pET16b-U3S, which is described elsewhere (Mathews 2001) 
and was kindly handed out by Prof. Heidi L. Schubert. All yielded fragments were loaded 
onto an agarose gel (1%) for purification by gel extraction. Purified fragments were all mixed 
for a final PCR reaction employing outer primers bearing restriction sites for XhoI and NdeI. 
The obtained gene was digested and cloned into a pET21a expression vector, yielding the 
construct pET21a-UShsMMap01. The final construct was sequenced at the sequencing 
facility of the Max Planck Institute in Tübingen, Germany.   
 
 
Figure 3.6 Gene assembly Chimeric gene construction was performed employing primers with complementary 
regions. In the first step, one fragment from the human U3S (orange) and two fragments from MCoAM (green) 
from Aeropyrum pernix were amplified in individual PCR reactions, using adequate primers (Section 5.3.1). 
These fragments were then assembled in a final PCR reaction, employing outer oligos to yield the hybrid gene, 
bearing restriction sites for NdeI and XhoI. 
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Protein expression of the parental and chimeric constructs was performed in BL21 cells at 
20°C and in ArcticExpress cells (Stratagene®) at 11°C (Section 6.11). The obtained cell 
pellets were mixed with Buffer-A and disrupted by sonication (Section 6.12). All proteins 
expressed solubly. However, the hybrid protein additionally showed high amounts of 
insoluble protein in inclusion bodies. Protein purification was performed via nickel affinity 
and size exclusion chromatography. Refolding was also performed to make use of the large 
amount of proteins in the inclusion bodies (Section 6.13). The refolded protein corresponded 
to the solubly expressed hybrid according to its biophysical characterization. Therefore, we 
used both proteins, treating them as equivalent.  
 
 
3.6. Biophysical characterization 
 
All proteins run as monomers when loaded onto an analytical gel filtration column (Figure 
3.7-A), and eluted as single peaks independent of their concentrations. Elution volumes and 
calculated molecular weight can be found in Table 3.1. Evaluation of the secondary structural 
content was carried out by circular dichroism (Section 6.17.2). As expected, the obtained 
curves corresponded to proteins containing ɑ and β structural elements and the shapes of their 
curves were very close to one another (Figure 3.7-B). Fluorescence spectra corresponding to 
the hybrid and parental U3S proteins were compared. Both signals showed a maximum at 317 
nm and a second shoulder at 333 nm (Figure 3.7-C). The presence of two peaks may result 
from two tryptophan residues that are more and less hidden from the solvent, or due to 
different conformers of the highly flexible proteins. Differences in intensity are likely due to 
the different content of chromophores, since the protein concentrations and buffers used were 
the same (Section 6.17.3). Thermal denaturation indicated that the hybrid protein is slightly 
less stable than the parental U3S and displays a two-step denaturation, perhaps owed to the 
fact that the fragments from MCoAM come from a thermostable organism and the one 
corresponding to U3S is from human (Figure 3.7-D).  
 
 
 
 
 
  
 45 
 
 
Figure 3.7 Biophysical characterization of parental proteins and hybrid UShsMMap01. Analytical gel 
filtration showed that all proteins eluted exclusively as monomers (A). Comparison of their CD spectra revealed 
similar signals characteristic of proteins containing ɑβ secondary structural elements (B). Fluorescence of 
parental U3S protein vs. the chimera showed different intensities due to distinct chromophore composition in 
their sequences. However, both displayed two defined peaks likely owed to the only two tryptophan residues, 
which are present in both constructs (C). Thermal denaturation revealed that the hybrid protein displayed a two-
step denaturation, perhaps due to different thermal stabilities of the parental fragments employed (extremophile 
vs. mesophilic). In addition, a decrease in thermal stability was observed in comparison to the parental protein 
(D). Color coding: hybrid protein UShsMMap01 in gray, parental proteins U3S and MCoAM in orange and 
green, respectively. Please refer to buffer section (Section 5.2.2) for details of solvent composition for each 
experiment. 
 
 
Table 3.1 Protein characterization by analytical gel filtration.  
___________________________________________________________________ 
Protein variant Elution volume [ml] Theoretical MW [kDa] Experimental MW [kDa] 
UShsMMap01 
U3S    
MCoAM 
13.0 
13.4 
14.8 
32.5  
31.0 
16.5 
39.6 
37.1 
16.9 
__________________________________________________________________________________________ 
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3.7. Structure determination and analysis  
 
Crystal growth. Protein crystals for UShsMMap01 were obtained at a concentration of 12 
mg/ml of a pure protein sample in a 96-well plate via the hanging drop method at 16°C. Each 
well contained 0.4 µl of protein sample and 0.4 µl of screening buffer. The best crystals grew 
in 0.1 M sodium cacodylate at pH 6.0 and 10 % PEG 4000. Crystal optimization was 
performed employing the same crystallization method, increasing the drop size to 1.5 µl under 
same buffer and temperature conditions. The obtained crystals were cryo-protected in 30% 
PEG 400 and frozen with liquid nitrogen before data collection.  
Data collection. Crystallographic experiments were carried out on the X10SA beamline at the 
Swiss Light Source, Paul Scherrer Institute (PSI) in Villingen, Switzerland. The data 
corresponding to a single crystal was collected at 100K and 0.5 oscillation degrees. The 
obtained images were recorded on a Pilatus 6M at a detector distance of 270 mm and a 
wavelength of 1.000Å. 
Structure determination. The obtained reflections were indexed, integrated and scaled with 
go.com. This software is a pipeline that includes: 1) XDS for indexing, integration, and data 
correction (Kabsch 2010), 2)  Pointless for space group determination (Evans 2006) , 3) Scala 
for scaling  (Evans 2006), 4) XDSCONV for conversion (Kabsch 2010) and 5) 
Phenix_xtriage (Adams et al. 2010) for data quality evaluation. Molecular replacement was 
performed with Phenix.phaser using pdb ids 2yxb and 1jr2 as assemble molecules, omitting 
the regions not present in the chimera.  An initial model was built using Phenix.autobuild 
(Adams et al. 2010). Final refinement resulted in R-work and R-free values at 19% and 24%, 
respectively. Final statistics corresponding to refinement are summarized in Appendix 7.4. 
Structure analysis. Elucidation of the hybrid structure revealed an unexpected orientation of 
the protein lobes (Figure 3.8), which behave as independent domains due to high flexibility at 
the connecting region. For instance, an antiparallel beta sheet connects the lobes in the 
parental U3S, which is shorter in the hybrid. In contrast, the fragments employed for chimeric 
building were highly similar to their parents, showing RMSD values of 1.0 Å over 129 Cɑ 
atoms for the MCoAM fragment and 0.8 Å over 129 Cɑ atoms for the U3S fragment, 
respectively.	A closer look at the crossovers revealed that the chimeric beta-strand at the N-
terminal cut site was successfully recreated and even elongated. However, the chimeric helix 
at the C-terminal crossover was disrupted right after the cut site (Figure 3.9). This issue 
appeared to result from a clash caused by residue Q198 as discussed in detail in Section 3.8.1, 
causing partial structural loss of the hybrid helix, conferring extra flexibility to the hybrid 
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lobes, which open and rotate 145 and 35°, respectively, compared to the U3S scaffold (Figure 
3.8).  
 
 
Figure 3.8 Structural analysis of chimeric variant UShsMMap01. Elucidation of the hybrid structure 
revealed an unexpected flexibility, which allows an increased opening and rotation angles in respect to the 
parental protein U3S of 145 and 35°, respectively.  
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Figure 3.9 Structural analysis of crossovers in UShsMMap01. N-terminal crossover showed that the chimeric 
beta strand (gray) became elongated with respect to the parental MCoAM (green), following the directionality of 
the parental U3S chain (orange). In contrast, the C-terminal cut site displayed a disruption of the resulting 
chimeric helix (gray) right at the transition between the parental sequences (red).   
 49 
3.8. Strategies for structural improvement 
 
Four different strategies were followed to decrease the flexibility between the lobes of the 
chimeric protein, resulting in 5 additional variants that are summarized in Figure 3.10. First, a 
clashing residue was eliminated to elongate helix 2, yielding UShsMMap02 (Section 3.8.1). 
In addition, we searched for residues in the U3S parental protein that seem to contribute to 
rigidity to the beta meander of the parental protein and inserted a mutation according to this 
finding. This resulted in UShsMMap03 (Section 3.8.2). In parallel, we eliminated a glycine 
residue in helix 2, anticipating that it may contribute to its disruption. Therefore, we mutated 
this glycine to an alanine, which is known to facilitate helix formation, as well as to a 
glutamate, which was present in several structures at this position of the U3S sequence 
profiles, resulting in variants UShsMMap04 and UShsMMap05 (Section 3.8.3). Finally, a 
helix cap was introduced to attempt helix elongation and restore the highly conserved 
sequence that is present in cobalamin-binding proteins at the end of helix 2. This modification 
yielded UShsMMap06 (Section 3.8.4).  
 
 50 
 
 
Figure 3.10 Different strategies for structural improvement. A clashing residue (Q198A) was eliminated 
(blue star), yielding UShsMMap02. Subsequently, an interaction in U3S parental protein that appears to join the 
connecting beta sheet to the lower lobe was introduced to the flavodoxin-like fragment (L225Y) resulting in 
variant UShsMMap03. Two additional variants were designed to elongate the helix at the crossover: First 
introducing G196A and finally G196E (pink and magenta stars, respectively). These mutations yielded variants 
UShsMMap04 and 05. A helix cap (TPEQ, purple cap) was introduced at the end of the transition helix to 
improve helicity, resulting in variant UShsMMap06. Fusion sites are shown as red squares. 
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3.8.1. Chimeric helix elongation via elimination of clashes 
 
As described in Section 3.4, definition of the C-terminal crossover was not as obvious as the 
N-terminal one, since the register of the aligned helices change slightly due to an insertion in 
U3S compared to MCoAM. In addition, the distance between helix 2 and the vicinal helix 3 is 
larger for U3S than for MCoAM (Figure 3.11). Anticipating that Q198 may clash in the 
resulting chimera, the Q198A mutation was introduced via directed mutagenesis (Section 
6.2.4). The yielded protein, termed UShsMMap02, behaved very similar to the original hybrid 
in terms of their biophysical characterization but the elucidation of its structure by X-ray 
crystallography (Appendix 7.5) revealed that the flexibility of the connecting loops was 
partially fixed (Figure 3.12). However, the two lobes remained distant, indicating that the 
Q198 residue contributed only partially to lobe aperture.  
 
 
 
Figure 3.11 Structural alignment of U3S onto MCoAM displays complications at C-terminal crossover. 
The helix H2 in the flavodoxin-like fold (green) is 2.9 Å closer to the protein core compared to its corresponding 
helix in hemD-like fold (orange). As a consequence, the transition at this helix gets disrupted by Q177 (Q198 in 
the chimera), which clashes in its new position (black). Residues in red illustrate the chimeric cut sites.  
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Figure 3.12 Structural improvements by Q198A mutation. The detected clashing glutamine residue was 
mutated to an alanine, extending the chimeric helix and decreasing the aperture distance between the lobes by 
about 45°. Protein model as surface and crystal structures as cartoon.    
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3.8.2. Searching for residue-residue contacts to favor interaction between lobes 
 
As an alternative strategy we searched in the parental U3S structure for interactions that may 
induce its mono domain architecture. We found that in the connecting beta-bridge the strands 
interact via π–π stacking through residues R65, F38, A172 and Y203 (Figure 3.13). All these 
residues are present in the hybrid except for Y203, which is located in the region replaced by 
the MCoAM fragment. In an attempt to restore a similar interaction, we mutated the 
corresponding residue in the chimeric protein, leucine 225, to a tyrosine. Unfortunately, the 
elucidation of this variant’s X-ray structure (Appendix 7.6) showed that the flexibility 
between the chimeric lobes could not be improved by this strategy. 
 
 
 
Figure 3.13 Structural improvement attempted via aromatic interactions. The U3S parental protein displays 
four residues that interact via π–π stacking (left). One of these residues, namely Y203 that was absent in the 
hybrid was introduced in a corresponding area, yielding UShsMMap03 (UShsMMap02-L225Y). Elucidation of 
its X-ray structure revealed that the introduced tyrosine did not interact as desired (right). 
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3.8.3. Further stabilization of the chimeric helix via mutations 
 
Another attempt to enlarge helix 2 was performed by mutating the residue G196. Glycine 
residues are well known for disrupting helices and even though this residue builds a helix in 
the parental U3S structure, it may not contribute to build a helical structure in its new amino 
acid environment. Therefore, we mutated this residue to an alanine (UShsMMap04) or a 
glutamate (UShsMMap05) (Figure 3.10). It is well known that alanine residues promote 
helicity. Glutamate was selected, since this residue was highly populated in the U3S 
sequence-profile at this position. Biophysical characterization of both variants corresponded 
to the original hybrid, being well folded and solubly-expressed. Nevertheless, only the variant 
G196A yielded good-quality protein crystals to solve a structure by X-ray crystallography. 
The elucidation of UShsMMap04 (Appendix 7.7) revealed that its conformation was similar 
to this of UShsMMap02, in which the protein lobes behave independently (Figure 3.14). 
Interestingly, the conformation of the aperture in these variants is different (Figure 3.15), 
corroborating further the high flexibility of the connecting loops observed for UShsMmap02 
as well. This property is also observed for the parental U3S proteins, which show apertures 
and rotation distances up to 90° and 26.6Å, respectively. 
 
 
Figure 3.14. Elucidation of the UShsMMap04 structure by X-ray crystallography.  The conformation of the 
protein lobes of UShsMMap04 is similar to UShsMMap02. The lobes also behave independently due to the high 
flexibility at the loops. Protein model is shown as surface and crystal structures as cartoon.  
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Figure 3.15  Structural alignment of U3S parental structure vs. UShsMMap02 and UShsMMap04. The 
crystal structures of UShsMMap02 (black) and 04 (pink) revealed a different relative orientation of their lobes, 
illustrating the high flexibility of their connecting loops.   
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3.8.4. Extension of chimeric helix through insertion of a helix cap 
 
The last attempt to extend the chimeric helix was through insertion of the helix-capping 
sequence QTPE. This sequence is highly conserved among the cobalamin-binding proteins. 
Therefore, we restored this sequence in the hybrid, yielding the UShsMMap06 variant, which 
in terms of its biophysical characterization corresponded to UShsMMap02. Attempts to solve 
the UShsMMap06 crystal structure failed, since the obtained crystals diffracted only at low 
resolution.  
 
Table 3.2 Crystallization conditions for chimeric variants 
 
protein  buffer/salt precipitant salt /additives 
UShsMMap02 a) 0.2 M lithium chloride pH 
7.4 
10% (w/v) PEG 6000  
 b) O.1 M HEPES 15% (w/v) PEG 4000 10 mM spermine 
tetrahydrochloride 
UShsMMap03 a) 0.1 M MES pH 7.0 30%  (v/v) Jeffamine ED 2001  
 b) 0.1 M sodium acetate pH 4.6 25%  (w/v) PEG 6000  
UShsMMap04 a) 0.1 M sodium HEPES pH 
7.5 
25% (w/v) PEG 3000  
 b) 0.1 M BIS-TRIS pH 6.5 20%  (w/v) PEG 5000 MME  
UShsMMap05 a) 0.2 M potassium sodium 
tartrate 
20% (w/v) PEG 3035  
 b) 0.1 M TRIS pH 8.0 1.5 M ammonium 
sulfate 
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3.9. Discussion 
 
Pursuing the hypothesis that homologous fragments, shared by different folds, can be 
combined to create solubly-expressed hybrids, we designed a fold-chimera, that in addition, 
addresses the question whether a cofactor-binding function can be transplanted from one fold 
to a different one. The fact that sequence-based profiles are able to find reciprocal regions that 
appear to be reused multiple times in different architectures may be an indication that these 
units carry advantageous features coded in their sequences, from which we can profit to create 
artificial proteins. Thus, the recombination of these fragments constitutes an alternative and 
innovative tool that offers a good starting point in terms of solubility. These protein templates 
can be improved by rational design or directed evolution. For instance, the flexibility of 
UShsMMap02 can be advantageous to bind others cofactors. In fact, a UShsMMap02-derived 
variant showed that the incorporation of a cysteine residue, in cooperation with a native 
histidine residue (H17), are able to bind heme (“Implementation and characterization of a 
heme-binding site in the chimera UShsMMap” (2018) master’s thesis by M.C. Hönle). This 
observation suggests that the independently-behaving lobes may associate to achieve binding, 
in a similar manner as the parental U3S traps its cognate ligand. Thus, despite donor and 
acceptor scaffolds may not be optimized for hybridization, they still yield well-behaving 
proteins, which is a good starting point for rational design. For instance, in this work the 
elimination of a clashing residue yielded significant structural improvements. Similarly, an 
earlier design attempting a chimeric TIM-barrel, showed the unanticipated formation of an 
additional beta strand (Bharat et al. 2008), an issue that was successfully solved with 
computational assistance (Eisenbeis et al. 2012). Overall, these unpredicted events teach us 
that computational algorithms must be employed to validate a protein model prior to its 
experimental characterization to improve the chances of success. Finally, we have proven that 
this approach not only yields proteins that can be expressed in E. coli, overcoming a major 
bottleneck of engineered proteins, but also provides the opportunity to combine existing 
functions that can be placed together economically and minimalistically for particular design 
purposes.  
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Chapter 4 
Cobalamin-binding characterization of UShsMMap02 
 
4.1. Overview 
 
 
As described in the previous chapter, a cobalamin-binding protein was designed, testing the 
hypothesis that existing binding pockets can be transplanted to remote related proteins, 
retaining their functions in the resulting chimeras. The long-term goal of such chimeric design 
is the usage of natural cofactors in the future to assist complex reactions in synthetic enzymes. 
One example of cofactors that has awakened particular interest in organic synthesis are 
cobalamins, which can be employed to synthesize non-natural organic molecules in an 
environmentally friendly setup and non-hazardous reaction conditions. Only recently, and for 
the very first time, a cobalamin-dependent methyltransferase has been modified to perform 
the reversible methylation of organic molecules in mild conditions, showing that engineered 
cobalamin-dependent enzymes are a promising alternative to the currently available protocols 
for organic synthesis. In this chapter, I describe the binding characterization of the protein 
variant UShsMMap02 (Section 3.8.1). Hereby, I employed photometric, calorimetric, 
colorimetric and crystallization methods to confirm the successful transfer of the cofactor-
binding function. 
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4.2. Cobalamins, ‘the most complex cofactors on earth’ 
 
The discovery of cobalamin (Cbl), also called vitamin B12 has its origins at the beginning of 
the 19th century. Back then, George H. Whipple, George R. Minot and William P. Murphy 
observed that cases of anemia pernicious, described already 100 years before, could be 
successfully treated with liver extract (Robscheit-Robbins and Whipple 1929; Richter 1933; 
Murphy 1932; Minot 1926). Based on this observation, this team of scientists predicted that 
liver may contain an ‘anti-anemia factor’ that prevented and healed this sickness. Thanks to 
this notable discovery, Whipple, Minot and Murphy were acknowledged with the Nobel Prize 
in Medicine and Physiology in 1934. About fifteen years later, Dorothy Hodgkin 
accomplished the elucidation of the vitamin molecule by X-ray crystallography (Hodgkin 
1958), which in 1964 earned her the Nobel prize in Chemistry as well.   
The cofactor crystal structure revealed an octahedral cobalt center coordinating four 
equatorial reduced pyrrole rings that build a corrin and seven amide chains attached to them. 
One of the macrocycle amides is bound to a nucleotide, whose moiety contains 5,6-
dimethylbenzimidazole (DMB) as base (Figure 4.1). DMB coordinates the cobalt center from 
its α-axial (lower) face, whereas a cyano group coordinates the β-axial (upper) one.  
It was not until the beginning of the 1970’s that scientists became aware that the cyano group 
attached to the cobalt was an artifact of its purification process and that the most biologically 
relevant molecules were methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), which 
coordinate a methyl and an adenosyl group instead. Since then, several publications have 
described the chemical and biological properties of this molecule (Kenneth L. Brown 2005; 
Ruma Banerjee 1999; Matthews 2009), including the titanic labor of elucidating the required 
enzymes for its full biosynthesis in aerobic (Debussche et al. 1993) and anaerobic organisms 
(Debussche et al. 1993; Schulze, Vogler, and Renz 1998), projects that involved decades of 
work and the enormous effort of more than a hundred scientists. 
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Figure 4.1 Cobalamin cofactors and derived molecules. Structurally, cobalamins are composed of a corrin 
ring (red), which is similar to the porphyrin ring of heme but contains cobalt as metal ion. This can be 
coordinated four to six times according to its redox state. In the hexa-coordinated form, the Co(III)balamin 
center displays four metallic bonds to the pyrrole rings, a β-axial coordination to a cyano (CN), methyl (Me), 
hydroxo (OH) or an adenosyl (Ado) group, and an ɑ-axial coordination to the 5,6-dimethylbenzimidazole 
(DMB) intramolecular base. In the Co(II)balamin form, either the β or ɑ coordination dissociates. Finally, 
Co(I)balamin presents no axial coordination. At physiological conditions, cobalamins display predominantly the 
so-called base-on conformation, in which DMB is coordinated to the cobalt. However, it is the base-off 
conformer that binds to cobalamin-dependent domains (Figure 3.1). By this process, the DMB-cobalamin 
coordination is displaced by a histidine residue to build the base-off his-on form. 
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4.3. The versatility of cobalamin-dependent catalysis 
 
To date, three families of cobalamin-dependent enzymes have been discovered: the 
adenosylcobalamin-dependent isomerases (Mancia and Evans 1998), the methylcobalamin-
dependent methyltransferases  (Hilhorst et al. 1993; Ghosh et al. 2018) and dehalogenases 
(Payne et al. 2015). Here, only the most prominent examples will be described briefly, 
summarizing the chemical aspects of cobalamin that are commonly exploited for their 
enzymatic function. 
 
4.3.1. Adenosylcobalamin-dependent isomerases 
 
The largest subfamily of cobalamin-dependent enzymes are isomerases. They play an 
exclusive role in fermentation pathways in bacteria (R. Banerjee 1997, 2001; Marsh and 
Drennan 1976), except methylmalonyl-CoA mutase, which is also found in humans. Another 
function that employs vitamin B12 for isomerization is driven by the ribonucleotide 
reductase, which assists the conversion of ribonucleotides to deoxyribonucleotides, taking 
part in DNA replication and repair (Stubbe 1983). All these isomerases exploit the chemical 
properties of the organometallic linkage of Co-adenosyl in adenosylcobalamin (AdoCbl), 
which is stable in water and shows a dissociation energy of approximately 31.5 kcal/mol for 
the base-off form (Finke and Hay 1984; Hay and Finke 1987; K. L. Brown and Zou 1999). 
This confers an inherent lability of the Co-adenosyl bond, resulting in a latent radical pool. 
However, this radical source can be activated only in the presence of a substrate (K. L. Brown 
and Zou 1999). In fact, only when the substrate is bound, the reaction accelerates a trillion-
fold, assisting the homolytic cleavage. Thus, the substrate-binding is the key energy control in 
all isomerase mechanisms that employ this cofactor.  
  
4.3.2. Methylcobalamin-dependent methyltransferases 
 
B12-dependent methyltransferases play an important role in one-carbon metabolism, carbon 
dioxide fixation and amino acid metabolism. All these reactions involve the transfer of a 
methyl donor to cobalamin and its further transfer to a methyl acceptor substrate. The most 
extensively studied B12-dependent methyltransferase constitutes the methionine synthase 
(MetH) from E. Coli, which catalyzes the methyl transfer from tetrahydrofolate to a Co(I) 
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form of Methylcobalamin yielding a CH3-Co(III) cobalamin intermediate from which the 
final methyl transfer to homocysteine is accomplished to synthesize methionine (Hall et al. 
2001; Huennekens et al. 1974). These transitions are modulated by a highly conserved 
histidine-aspartate-serine triad, which is key in controlling the coordination state of cobalt 
(His-on/His-off) by modulating the protonation state of the histidine. 
Another group of B12-dependent methyltransferases are O-demethylases, which are essential 
for acetogenic microbes. These enzymes catalyze the demethylation of aromatic methyl 
ethers. In this process, the ether oxygen remains in the phenolic product (DeWeerd et al. 
1988), which is further excreted and the methyl group is further metabolized by the Wood-
Ljungdahl pathway (Payne et al. 2015; Ragsdale 2008). Similar to MetH, O-demethylases 
employ a three-component system (Naidu and Ragsdale 2001), here however, the methyl 
group is donated by the phenylmethylether to cobalamin to form a CH3-Co(III) from which 
the methyl group is finally transferred to tetrahydrofolate (Naidu and Ragsdale 2001; Berman 
and Frazer 1992; el Kasmi, Rajasekharan, and Ragsdale 1994).  
 
4.3.3. Cobalamin-dependent dehalogenases   
 
There are two main known classes of anaerobic dehalogenases: heme-containing (Ni, 
Fredrickson, and Xun 1995) and cobalamin-dependent enzymes (Christiansen et al. 1998; van 
de Pas et al. 1999). Reductive dehalogenation reactions play an important role in the 
detoxification of aliphatic and aromatic chlorinated molecules (Copley 1998; Janssen, 
Oppentocht, and Poelarends 2001). Cobalamin-dependent dehalogenases are poorly 
understood, however, it is known that the role of cobalamin in their reactions is significantly 
different from other cobalamin-dependent enzymes and  two potential mechanism models 
have been proposed (Miller, Wohlfarth, and Diekert 1997; Neumann, Wohlfarth, and Diekert 
1995; Krone, Thauer, and Hogenkamp 1989).  
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4.4. Employing cobalamin for artificial methylation 
 
Synthetic reactions for methylation and demethylation are of great value. For instance, O-
methylated phenols are indispensable building blocks for the synthesis of antioxidants, 
artificial flavors, dyes, fragrances, and agricultural chemicals (Law et al. 2016; M.-X. Zhang 
et al. 2015; Lee et al. 2017). Several reaction protocols are currently available for methylation 
and demethylation (Cody 2007). However, these reactions rely on toxic and corrosive 
reagents (Selva and Perosa 2008; W. E. Wymann et al. 1989; Walter E. Wymann et al. 1988)  
and are neither chemo nor regioselective. In addition, none of the currently available methods 
allow the reversible C-O-ether formation or demethylation in a large scale. Due to the high 
resistance of O-methyl ethers against hydrolysis, their cleavage usually requires the usage of 
strong Bronsted reactants (Fredriksson and Stone-Elander 2002; Hart, Aldous, and Harper 
2017), Lewis acids (McOmie, Watts, and West 1968; Pasquini and Bassetti 2010) or metal 
catalysts  (Cornella, Zarate, and Martin 2014; Yang et al. 2016). Only in the last decade, 
biocatalysts have gained attention as complementary or even as substitution to the 
conventional chemical approaches. They not only offer mild, sustainable and selective 
reactions (Patel 2011; Hönig et al. 2017; Sheldon and Woodley 2018), but also a broad 
repertoire of biosynthesis (Bornscheuer 2018; Turner and O’Reilly 2013; Chen et al. 2018), 
since reactions involving methylation are widely represented in Nature (Copeland, Solomon, 
and Richon 2009; Liscombe, Louie, and Noel 2012; Struck et al. 2012). Only recently, 
Farnberger and colleagues minimized the tetra-component system of a cobalamin-dependent 
methyltransferase to a bi-component biocatalyst. This system allows both methylation and 
demethylation in a reversible manner (Farnberger et al. 2018) and shows the utility of a 
methyl transfer concept based on corrinoid-assisted catalysis. The system is not only 
sustainable, safe and scalable but also not limited to natural substrates nor by cofactor 
turnover. We envision the cobalamin-dependent methylation as a promising add-on to organic 
synthesis. For instance, employing the fold-chimera approach described in Chapter 3, we 
may be able to place a desired binding pocket in close proximity to the cofactor, in that 
manner, assisting methylation of novel substrates by exploiting the highly nucleophilic nature 
of methylcobalamin.  
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4.5. Cobalamin- binding characterization of UShsMMap02 
 
Under physiological conditions cobalamins exist in three different oxidation forms: Co(I), 
Co(II) and Co(III) (Figure 4.2). These forms are the basis of the chemical reactions assisted 
by this cofactor since the coordination of the axial ligands to the cobalt center depends on the 
formal oxidation state of the metal. As a rule, the number of ligands attached to cobalt 
decreases with the oxidation state of this metal. For instance, in cobalamin Co(III) is hexa 
coordinated, Co(II) penta coordinated, and Co(I) tetra coordinated, meaning the metal does 
not ligate beyond its coordinating corrin ring. Each oxidation state has a particular color. This 
physicochemical property is very useful, since the oxidation state can be validated simply by 
sight. In addition, the fact that cobalamins are natural chromophores can be exploited for 
binding analysis on proteins, since the protein-cofactor complex will display the characteristic 
color of the particular cobalamin form bound -a feature, which allows the application of UV-
vis spectroscopy to define changes in the electronic environment of the corrin ring. Any 
change around the metal can be detected by this technique, such as the redox state but also the 
nature of a particular ligand attached to the cobalt. 
 
 
 
 
4.2 Cobalamin redox forms. The cobalt center in cobalamins can adopt three oxidation states: (1) Co(I), a super 
nucleophile that has no α- or β-axial ligands and shows a characteristic brown color. (2) Co(II), which binds 
either an α- or a β-axial ligand, and displays an orange color. Finally, Co(III), which binds both, α- and β-axial 
ligands, displaying a red color. The α-axial coordination occurs intramolecularly to the molecule base, which is 
usually 5,6-dimethylbenzimidazole (DMB). 
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4.5.1. Analytical gel filtration in the presence of cobalamins   
 
Taking advantage of the particular colors of cobalamins, we carried out an analytical gel 
filtration, using a sample of UShsMMap02 in the presence of four different cobalamins. 
Hereby, the individual cofactors were mixed in 20-fold excess with a pure protein sample and 
incubated for 30 minutes prior to loading. As positive control, the cobalamin-binding domain 
of methylmalonyl-CoA mutase from Aeropyrum pernix (parental protein) was also tested with 
each of the cobalamins under the same conditions. Both proteins eluates were red (indicative 
of cobalamin in its Co(III) redox state. This color remained even after dialysis against buffer 
without Cbl (Figure 4.3-A), indicating that Cbl does not easily dissociate from the hybrid 
upon dilution. In addition, concentration of the protein-Cbl complexes in a centrifugal filter (3 
kDa) showed an increased red color in the concentrating eluates, whereas the flow through 
was transparent (Figure 4.3-B). Finally, the presence of Cbls in both protein eluates was 
confirmed by absorbance at 361 nm (Figure 4.3-C-D). 
Despite the evident protein-cofactor formation, we were concerned that cobalamin could bind 
nonspecifically, for instance through displacement of the β-axial ligands by histidine or 
cysteine residues instead of proper insertion of its nucleotide moiety into the protein core, and 
ligation of the cis-face of the cobalamin with the putative native histidine residue (figure 4.1). 
Therefore, the cyanocobalamin (CNCbl) sample was of particular interest. Its strong Co-CN 
bond is highly stable compared to alkylcobalamins and does not dissociate under light 
exposure (Kozlowski et al. 2016). Thus, we co-refolded UShsMMap02 in presence of CNCbl 
and run an analytical gel filtration to get rid of the unbound cobalamin (Figure 4.3-E). The 
formation of a protein-CNCbl complex strongly suggests the proper cobalamin-binding, 
involving displacement of the DMB base, which can be corroborated photometrically as well 
(Section 4.5.2). To validate the stability of the protein-CNCbl complex, the eluted hybrid-
CNCbl complex was loaded again onto an analytical gel filtration (without adding extra 
CNCbl). The second run showed that the majority of the cofactor remained bound to the 
protein (Figure 4.3-F), suggesting that the binding affinity is at least in the low millimolar 
range. 
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Figure 4.3 Analytical gel filtration of MCoAM and UShsMMap02 in presence of cyanocobalamin. The 
protein-cobalamin complex can be isolated via gel filtration as indicated by the red color of the sample after 
dialysis (A) or concentration (B). Analytical gel filtration of MCoAM-CNCbl (C) and UShsMMap02-CNCbl 
(D) samples. Analytical gel filtration of refolded UShsMMap02 in presence of CNCbl (E). A second run, 
employing the eluted hybrid-CNCbl sample showed poor CNCbl dissociation from the hybrid proteni (F). The 
protein-CNCbl samples were contained in 20 mM Tris at pH 7.4, 300 mM NaCl and 1 mM β-mercaptoethanol. 
CNCbl was tracked photometrically at 361 nm (black dashed line) and proteins at 280 nm (green and orange 
solid lines).  
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4.5.2. Photometrical analysis of cobalamins bound to the hybrid chimera 
 
The UV-visible spectra of cobalamins are well described in the literature and provide a useful 
diagnostic for oxidation and ligation forms (Tsiminis et al. 2017; Dolphin 1971; Denis S. 
Salnikov et al. 2011; D. S. Salnikov and Makarov 2019; Dassanayake et al. 2016; Kim, 
Gherasim, and Banerjee 2008). Therefore, we performed UV-vis photometric studies on free 
and bound Cbls, resulting from the analytical gel filtration experiments described in the 
previous section. We found that adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl) 
lose their β-axial ligands upon binding to both, parental and hybrid proteins, leading to the 
typical spectrum of hydroxocobalamin (Figure 4.4-A). It is known that AdoCbl and MeCbl 
are less stable than CNCbl or OHCbl when exposed to light (Cole et al. 2002). However, the 
spectral changes observe here are not due to photolytic cleavage. As control, cobalamin 
samples without protein were incubated under the same conditions, showing no UV-vis 
spectral changes. In fact, the photolysis rates of base-off cobalamins are very different from 
their base-on analogs (Peng et al. 2010). The lack of the DMB coordination alters the 
electronic nature of the cofactor, opening a channel for fast non radiative decay, which is 
comparable to the Co-C bond photodissociation. This means that the cleavage of beta Co-
coordinated ligands will dissociate faster from Cbl bound to the protein compared to free Cbl 
in solution. This is the reason why base-off Cbls are excellent agents for methylation.  
As a parallel control, a titration with imidazole on free OHCbl was performed to test whether 
the observed photometric changes were due to imidazole bound to cobalamin as an artifact of 
the Ni-affinity chromatography instead of histidine ligation. In fact, the spectral changes were 
very similar (Figure 4.4-B). however, later binding studies with CNCbl corroborated that the 
cyano group remains on Cbl, speaking in favor of a proper insertion of the cofactor instead of 
β-axial coordination to imidazole. 
Special attention has to be paid to the use of reducing agents such as β-mercaptoethanol, since 
this molecule reduces AdoCbl, MeCbl and OHCbl, and displaces the β-axial ligand (Figure 
4.4-C). Thus, to avoid spectral changes owed to photo-lability and reduction, we proceeded in 
the photometric characterization exclusively with CNCbl. Only small spectral changes were 
observed in the presence of CNCbl (Figure 4.4.-D) compared to other CNCbl-binding 
proteins (Figure 4.4-D) (Kim, Gherasim, and Banerjee 2008) However, the spectrum of the 
eluted hybrid-CNCbl complex displayed the typical signal of CNCbl (Figure 4.4-E to F), 
indicating that binding to the protein likely occurs via insertion of its nucleotide moiety 
instead of replacement of the β-axial ligand, e.g. by residues such as histidine or cysteine. 
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Figure 4.4 UV-vis analysis of UShsMMap02 with cobalamins. Spectral changes of free methylcobalamin 
(dashed) and bound to UShsMMap02 (solid line) after elution from gel filtration (A). Spectral changes of OHCbl 
(40 µM) upon addition of imidazole (B). Reductive titration of OHCbl (40 µM) with β-mercaptoethanol (C). 
Photometric changes upon binding of CNCbl (dashed line) to UShsMMap02 (solid line) (D). UV-vis absorbance 
spectra of free CNCbl (dashed line) and bound to MMACHC trafficking chaperone (E). Comparison between 
base-on (dashed line) and base-off (solid line) CNCbl in water and 6% HClO4, respectively (F). Captions (E) 
and (F) were adapted from “Decyanation of vitamin B12 by a trafficking chaperone” by Jihoe Kim, Carmen 
Gherasim, and Ruma Banerjee (2008). 
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4.5.3. Cobalamin binding analysis on UShsMMap02 in anaerobic conditions 
 
In a parallel attempt to promote the base-off conformation of cobalamin and assist its binding 
to the hybrid protein, samples containing MeCbl, OHCbl and AdoCbl were reduced 
employing ascorbic acid. Reduction of Co(III)balamin to Co(II)balamin, in anaerobic 
conditions, results in a base-off form, which is stable in the absence of oxygen. Therefore, all 
buffers and samples employed were prepared in an anaerobic glove box under anoxic 
conditions. Hereby, the cofactor samples were added to the hybrid protein and incubated for 
30 minutes. After this time, a bench gel filtration column was loaded with the protein-cofactor 
mixture to separate the unbound Cbl. Unexpectedly, the cobalamin bound to the protein had a 
different color than the free (reduced) cobalamin (Figure 4.5). It was anticipated that all Cbl 
molecules would adopt a base-off reduced conformation and, therefore, would display the 
characteristic orange color of Co(II)balamin. However, the protein-Cbl complex displayed the 
characteristic red color of Co(III)balamins, indicating that the cobalamin form attached to the 
protein is hexa-coordinated. How exactly the transition from Co(II) to Co(III) occurs, remains 
unclear. While the co(II) form of Cbl should be stable in anaerobic conditions, its association 
with the protein changes its chemical properties. 
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Figure 4.5 Isolation of UShsMMap02-cobalamin complex under anaerobic conditions. At physiological pH 
cobalamins can be converted to their base-off form via addition of reducing agents. For example, ascorbic acid 
reduces Co(III)balamins to their Co(II)balamin form (orange), which is stable in anaerobic conditions. Addition 
of the protein hybrid to a Co(II)balamin solution favours the transition to Co(III)balamin (red). The yielded 
protein-Co(III)balamin complex (fractions 1 and 2) can be isolated from free Co(II)balamin (fraction 3) via gel 
filtration as indicated by its red color, whereas the free Co(II)balamin displays the characteristic orange color of 
this form. 
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4.5.4. Isothermal titration calorimetry analysis of cyanocobalamin on fold-hybrid 
 
To determine the binding affinity of cobalamin to the hybrid protein, a cyanocobalamin 
solution at 3 mM was titrated in steps of 2 µl to a protein solution (300 µl) of refolded 
UShsMMap02 at 282 µM (Methods 6.19.3) Unexpectedly, the addition of cofactor did not 
show significant heat changes upon titrations (Figure 4.6). These observations do not 
correspond to the previous characterization methods via gel filtration and UV-vis 
spectrometry. However, it is evident that the protein-cofactor complex is formed since it can 
be isolated via size exclusion chromatography and remains even after a second gel filtration 
run. It remains unclear why no changes in protein-ligand thermodynamics cloud be detected; 
however, Cbl loading onto protein is complex. This process is often performed by chaperones 
in the cells and might take longer times, which may explain this observation.  
 
 
Figure 4.6 Isothermal titration calorimetry measurements with cyanocobalamin. A UShsMMap02 protein 
sample at 282 µM (300 µl) was titrated with 2 µl injections of a cyanocobalamin solution (3 mM) in 20 mM 
TRIS (pH 7.4), 100 mM NaCl, and 1 mM β-mercaptoethanol (Methods 6.19.3). No significant  thermodynamic 
changes were detected upon addition of ligand. The measurements were carried out on a NanoITC isothermal 
titration calorimeter. 
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4.5.5. Crystallization in the presence of cobalamin and derived molecules 
 
Co-crystallization  
Crystal screenings were assessed for UShsMMap02 in the presence of six different vitamin 
B12 derivatives (Table 4.1.) First, four different cobalamins: methylcobalamin, 
hydroxocobalamin, adenosylcobalamin and cyanocobalamin were added (individually) in 20-
fold excess to the protein sample at 12 mg/ml and incubated for at least 30 minutes. The 
samples were employed for co-crystallization trials via the hanging drop method as described 
in Section 6.17.1. None of the conditions yielded crystals, perhaps due to the large amount of 
cofactor added, considering that cobalamins are large molecules that may interfere with the 
crystallization process. To improve the chances of nucleation, samples of the four protein-Cbl 
complexes, previously isolated through size exclusion chromatography, were screened. Only 
one condition yielded one pink crystal (Figure 4.7-B). However, it diffracted at low 
resolution (up to 9Å) and improvement attempts (Section 6.17.2) did not succeed.  
Since UShsMMap02 could not be crystallized in complex with any Cbl form, two derivatives 
were tried: (1) ɑ-ribazole-3’-phosphate (ɑR3P) and (2) 5,6-dimethylbenzimidazole (DMB). 
The first constitutes the nucleotide moiety of cobalamins (Figure 4.7-A), which has been 
shown to bind to the cobalamin-binding domain of the glutamate mutase (Tollinger et al. 
2001). Therefore, hanging drops experiments with this molecule were assessed. Since this 
molecule is not available for purchase, it was synthesized by hydrolysis of cyanocobalamin by 
my colleague Bruce Lichtenstein (Methods 6.20). In addition to ɑR3P, it was predicted that 
the DMB base may be able to bind as well and co-crystallization trays were also set in the 
presence of this ligand. Both experiments produced crystals (Table 4.1). However, crystals 
with ɑR3P were highly amorphous (Figure 4.7-C) and diffracted only at resolution above 4Å. 
In contrast, co-crystallization with DMB grew good quality crystals for structure 
determination. The crystals were handled and measured as described in Section 6.17.3. The 
best dataset was collected at 2.4Å and processed with the XDS package (Adams et al. 2010). 
Molecular replacement was performed with Phenix.phaser using pdb ids 2yxb and 1jr2 as 
separate assemble molecules. Final refinement (Appendix 7.8) resulted in R-work and R-free 
values at 25% and 26%, respectively. To corroborate the presence of the ligand, a difference 
2Fo – Fc density map was calculated, showing density in the binding pocket region (Figure 
4.8-A) at a sigma value of 1.0 (Figure 4.8-B). Finally, ligand-residue contacts were generated 
with LigPlot+ (Wallace et al. 1995) (Figure 4.8-C to D). 
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Figure 4.7 Co-crystallization and soaking experiments. Six cobalamin derivatives were employed for 
crystallization. Four cobalamins: adenosylcobalamin, methylcobalamin, hydroxocobalamin and cyanocobalamin; 
and two truncated molecules: alpha-ribazole-3’-phosphate (ɑR3P, yellow dashed) and 5,6-
dimethylbenzimidazole (DMB, blue dashed) (A). Co-crystallization with cobalamins yielded only one 
amorphous crystal in the presence of OHCbl (B), which diffracted at low resolution (9Å). Co-crystallization with 
ɑR3P, also gave amorphous crystals, which diffracted up to 4Å (C). Apo crystals (D) were soaked with DMB, 
ɑR3P and Cbls. The latter led to disruption of the crystal lattices (E). 
 
Table 4.1 Crystallization attempts with cobalamin derivatives. 
__________________________________________________________________________________________ 
Method Ligand Crystals Successful condition  Res 
(Å) 
Structure Occupancy 
Co-crystallization MeCbl 
OHCbl 
AdoCbl 
CNCbl 
❌
 
✔ ❌
 ❌
 
1 M Succinic acid, 
0.1 M HEPES pH 7.0, 
15 % (w/v) PEG 
MME 2000 
- 
- 
- 
- 
 
❌
 ❌
 ❌
 ❌
 
 
 
 ɑR3P 
DMB 
✔ 
✔ 
0.1 M HEPES, 20% 
PEG 400 pH 6.8 
4.0 
2.7 
❌
 
✔ 
- 
100% (DMB) 
 
Soaking 
 
MeCbl 
OHCbl 
AdoCbl 
CHCbl 
 
❌
 
❌
 
❌
 
❌
 
 
 
 
 
 
 
 
 
 
 
- 
- 
- 
- 
 
❌
 
❌
 
❌
 
❌
 
 
 ɑR3P 
DMB 
 
✔ 
✔ 
0.1 M Tris, 15% PEG 
4000 pH 5.7 
2.2 
2.4 
✔ 
✔ 
 
100% (PEG) 
100% (PEG) 
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Figure 4.8 Crystal structure of UShsMMap02 in complex with DMB. The crystal structure of UShsMMap02 
(gray) in complex with DMB (black) provides insights for cobalamin binding. This molecule binds to 
UShsMMap02 in the Cbl-binding area, as corroborated by the structural alignment to the cobalamin-binding 
domain of glutamate mutase from E. coli (green, pdb: 1bmt) (A) The difference 2Fo – Fc electron density map at 
1,0σ shows electronic density in the expected binding region (B). Ligand-residue contacts were calculated with 
LigPlo+ (Wallace et al. 1995) (C-D).  
  
V40
V125 V215
G214
S216
G246
DMB
A) B)
C) D)
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Soaking 
The apo crystals showed a resolution of 2.0Å. Therefore, we soaked these with the same 
ligands mentioned in Table 4.1. The crystals soaked with cobalamins became damaged after 
few minutes of incubation (Figure 4.7-E), likely owed to the tight crystal packing in absence 
of ligand, which may become disrupted in the process of binding of the large ligand. In 
contrast, soaking with ɑR3P and DMB did not affected the crystal quality substantially, which 
remained intact after incubations of longer than 24 hours, as the apo crystals (Figure 4.7-D). 
 
 
The obtained crystals were fished with X-ray mounting loops in adequate sizes and 
cryoprotected in 30% (v/v) PEG 400 dissolved in the crystal mother liquor employed for 
soaking. These crystals were finally cryocooled by plunging them into liquid nitrogen prior to 
data collection on the X10SA beamline at the Berliner Elektronenspeicherring-Gesellschaft 
für Synchrotronstrahlung (BESSY). The data was collected at 100K and 0.5 oscillation 
degrees. The obtained images were recorded on a Pixel-detector Pilatus 2M at a distance of 
270 nm and a wavelength of 1.000Å. Two datasets at 2.4 (DMB) and 2.2Å (ɑR3P) were 
collected. The obtained reflections were indexed, integrated and scaled  with the XDS 
package (Kabsch 2010). Molecular replacement and refinement were performed with Phenix 
(Adams et al. 2010), as for UShsMMap02 and the final refinements are summarized in 
Appendix 7.9 to 10. Unexpectedly, the binding pocket in both structures was occupied by a 
PEG molecule instead of the desired molecules (Figure 4.9). This is likely due to the high 
concentration of PEG 400 (30%) added to the soaking conditions. We know from the co-
crystallization attempts with DMB that this ligand successfully fills the Cbl binding pocket. 
Thus, improving the resolution of co-crystallized crystals with ɑR3P may yield a hybrid 
structure in complex with this ligand as well.  
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Figure 4.9 UShsMMap02 crystal structure in complex with PEG. Soaking attempts with ɑR3P and DMB 
failed to incorporate these ligands. The elucidation of both structures showed PEG in the cobalamin binding 
pocket instead of the soaked ligands. Difference 2Fo – Fc density electron density map observed at 1.0 σ.  
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4.6. Mutation of the cobalt-coordinating H17 in UShsMMap02 does not 
impair cobalamin binding 
 
The first solved structure of cobalamin bound to a protein was the methionine synthase from 
E. coli. This structure revealed how the cofactor base is displaced by His579 to build its base-
off/His-on conformation. Due to the high conservation of this residue among the cobalamin-
binding units, we anticipated that this histidine (H17 in our construct), would be necessary for 
proper cobalamin binding. Thus, we generated a UShsMMap02-H17A mutant as control and 
performed its binding characterization by analytical gel filtration and UV-vis 
spectrophotometer. However, binding analysis by gel filtration showed that this variant still 
binds to cobalamin, showing a characteristic red coloration after elution. A deeper research in 
the literature revealed that previous mutagenesis analysis on the methionine synthase showed 
that mutation of any of the catalytic triad Ser-Asp-His has an impact on reaction rate but not 
on binding (Matthews R.G. (2009) “Cobalamin- and corrinoid-Dependent enzymes” Vol. 6: 
Roya Society of Chemistry). Thus, USHsMMap02-H17A is not a suitable negative control for 
binding.  
4.7. Mimicking CarH activation mechanisms to limit UShsMMap02 flexibility 
 
Only recently, the underlying principles of gene expression regulation by the cobalamin-
dependent photoreceptor CarH were elucidated (Jost et al. 2015). This enzyme senses light 
with help of adenosylcobalamin (AdoCbl), whose Co-adenosyl bond is the basis for the 
regulatory function. For instance, in the presence of light, the Co-Ado bond dissociates and 
the cobalt center coordinates a histidine residue (Figure 4.10-A). This leads to a 
conformational change that induces dissociation of the CarH tetrameric assembly. Inspired by 
this sophisticated mechanism, I introduced five histidine mutations at the upper lobe interface 
of UShsMMap02 (Figure 4.10-B to C) to confer structural rigidity to the independently-
behaving hybrid lobes upon Cbl binding. The mutations either replace existing residues 
(S84H and G121H) or are insertions located before residues S63, G141 and G165. These 
mutations may not only decrease the structural flexibility of UShsMMap02, but also facilitate 
double cobalt coordination (His-Co-His), which can be validated photometrically. However, 
the characterization of these constructs (Section 5.4.3) remains to be performed.  
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Figure 4.10 CarH activation mechanism and its application to improve UShsMMap hybrids. Activation of 
the adenosylcobalamin-dependent CarH photoreceptor is induced under light exposure, leading to dissociation of 
the adenosyl moiety from AdoCbl. By this process, its coordination to cobalt is replaced by a histidine residue 
(A). Five histidine mutations (black) (Section 5.4.3) were introduced at the upper UShsMMao02 interface to 
mimic the bis-his coordination of CarH (B-C). Caption (A) adapted from “The photochemical mechanism of a 
B12-dependent photoreceptor protein” by Jones A.R., Nature Communications, page 3 (2018). 
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4.8. Discussion 
 
The goal of transplanting a cofactor-binding function from one fold into a different one was 
accomplished in this work. A hybrid-Cbl complex was successfully isolated via analytical gel 
filtration, which presents the red color characteristic of Co(III)balamins and was corroborated 
via UV-vis spectroscopy. Moreover, the hybrid-Cbl complex is relatively stable, since a 
second gel filtration run showed that only a small fraction of the cofactor dissociates from the 
designed protein. Despite these findings, the ITC experiments with CNCbl did not show any 
heat changes upon titration. However, the UV-vis spectra with the same ligand corroborated  
the cyano group remains axially bound to the cofactor, meaning that cobalamin-binding to the 
protein likely occurs via displacement of the DMB intramolecular interaction to Co. 
Supporting this hypothesis, the elucidation of the UShsMMap02 structure in presence of 
DMB showed binding to the protein in the expected B12-binding region.  
 
To support the binding and structural evidence presented in this work, electron paramagnetic 
resonance (EPR) experiments can be performed, since EPR spectra are sensitive to the 
coordination state of Cbls and are helpful to differentiate base-off/His-on conformers from 
their base-on species. In addition, crystallization and ITC trials can be assessed with so-called 
pseudo cobalamins, which adopt exclusively a base-off conformation. Nevertheless, these 
compounds are not available for purchase and have to be synthesized.  
 
Overall, these results illustrate that the recycling of prosthetic groups can be exploited for the 
design of proteins. Thus, the combinatorial protocol described in Chapter 3, may allow the 
reuse of naturally occurring cofactors, providing a wide range of reaction alternatives to be 
combined. Particularly the usage of large cofactors such as cobalamins, sulfur-iron clusters or 
heme are excellent catalysts that assist highly complex reactions. In fact, the later has been 
shown to bind to a UShsMMap-derived protein (“Implementation and characterization of a 
heme-binding site in the chimera UShsMMap” (2018) master’s thesis by M.C. Hönle, 
University of Bayreuth), demonstrating that this approach is a good starting point for the 
design of novel functionalities in the future.   
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Chapter 5 
Instruments and materials 
 
4.1. Equipment 
 
5.1.1  Centrifuges 
● Beckmann Coultier Avanti J-26xPI (Avanti) 
● Biofuge table centrifuge 5425 (Eppendorf) 
● Centrifuge 5810R (Eppendorf) 
5.1.2  Chromatography 
● AEkta Pure 25M (GE healthcare) 
● AEkta Pure P900 (GE healthcare) 
● AEkta Pure Prime (GE healthcare) 
5.1.3 Crystallization 
● Honeybee 963 crystallization robot (Genomic Solutions) 
● Rock Imager 182 Imaging System with UV optics (Formulatrix) 
● Mosquito crystallization robot (TTP) 
5.1.4  Isothermal titration calorimetry  
● NanoITC isothermal titration calorimeter (TA Instruments) 
5.1.5 Scales 
● Kern 572 
● Kern Fine Scale ALS120-4 
5.1.6 Spectrophotometer  
● Jasco J-810 CD-Spectrometer 
● Jasco FP-6500 fluorescence-spectrometer 
● Varian Cary 50 Scan UV-VIS spectrometer 
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5.1.7 Thermocycler 
● Biometra T3000 Thermocycler 
● BioRad MyCycler Thermocycler  
5.1.8  Shakers 
● IINOVA® 44 incubator (New Brunswick Scientific) 
● Multitron II (Infors) 
5.1.9  Miscellaneous 
● Branson Digital sonifier W-250  
● Hanna pH211 microprocessor pH meter 
● Olaf Waase Thermoblock 
● Anaerobic Glove Box Coy Lab (© MR)  
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5.2  Material 
 
5.2.1 Bacterial strains  
● Arctic Express (Stratagene) 
● BL21 StarT M (Invitrogen) 
● DH5α (Life Technologies) 
● Top10 (Invitrogen)  
        
5.2.2 Buffers and solutions 
 
5.2.2.1 Cloning 
● TAE-Buffer (242g Tris, 57.1ml acetic acid, 37.2 EDTA in 1L) 
● Agarose solution 1%: 1% agarose in TAE  
● Agarose solution 2%: 2% agarose in TAE    
● 1000× ampicillin stock solution: 100mg/ml Na-ampicillin in water 
● BDT-mix: Obtained from in-house sequencing service  
● Ethidium bromide stock solution: 10 mg/ml ethidium bromide in water 
● 2x SDS sample buffer (100 mM TRIS pH 6.8, 20 % Glycerol, 4 % 
SDS, 200 mM)  
 
5.2.2.2 Protein expression 
● 1000× IPTG stock solution: 1 M IPTG in water 
● LB Medium For 1l: 10g pepton from bacteria, 5g NaCl, 5g yeast 
extract 
● TB medium For 1l: 24g yeast extract, 12g tryptone, 4ml glycerol, 2.31g 
KH2PO4, 12.54g K2HPO4 
 
5.2.2.3 Protein purification     
● Buffer-A1 (20 mM Tris pH 7.4, 100 mM NaCl, 1 mM B-mcpto EtOH 
and 15 mM imidazole) 
● Buffer-B1 (20 mM Tris pH 7.4, 100 mM NaCl, 1 mM B-mcpto EtOH 
and 500 mM imidazole) 
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● Buffer-A2 (50 mM HEPES pH 7.4, 100 mM NaCl, 1 mM B-mcpto 
EtOH and 15 mM imidazole) 
● Buffer-B2 (50 mM HEPES, 100 mM NaCl, 1 mM B-mcpto EtOH and 
500 mM imidazole) 
● Buffer-A3 (50 mM KP pH8, 150 mM KCl) 
● Buffer-B3 (50 mM KP pH8, 150 mM KCl, 500 mM) 
 
5.2.2.4 Circular dichroism 
● CD-buffer (10 mM phosphate buffer  pH 8) 
 
5.2.2.5 Isothermal titration calorimetry  
● ITC-buffer (20mM Tris pH7.4, 100mM NaCl, 1mM β-
mercaptoethanol) 
 
5.2.2.6 Refolding 
● R1-buffer (50 mM Tris pH 7.4, 6M guanidinium chloride, 300mM 
sodium chloride) 
● R2-buffer (50 mM Tris pH 7,5, 1 M guanidinium chloride, 300mM 
sodium chloride) 
● R3-buffer (50 mM Tris pH 7,5, 2 M guanidinium chloride, 300mM 
sodium chloride) 
 
5.2.2.7 Gel filtration 
● GeFi-buffer-1 (20 mM Tris pH 7.4, 300mM sodium chloride, 1mM β-
mercaptoethanol) 
● GeFi-buffer-2 (50 HEPES Tris pH 7.4, 300mM sodium chloride, 1mM 
β-mercaptoethanol) 
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5.2.3. Chemicals 
 
 
β-mercaptoethanol Brand   
Carl ROTH® 
Formula  C2H6OS  
MW  78.13 g/mol 
Purity  99%  
Cyanocobalamin (B12) 
Brand   Sigma-Aldrich ®  
Formula   C63H88CoN14O14P  
MW   1355.37 g/mol 
Purity   ≥98% 
Ethanol   
Brand  Carl ROTH® 
Formula   C2H5OH 
MW 46.07 g/mol 
Purity 99.9% 
Guanidine hydrochloride   
Brand   Carl ROTH® 
Formula   CH5N3 * HCL 
MW   95.53 g/mol 
Purity   99.5% 
Hydrochloric acid   
Brand   Carl ROTH® 
Formula   HCL 
WW   36.46 g/mol 
Purity   37% 
Vitamin B12a hydrochloride 
Brand   Sigma-Aldrich ®  
Formula C62H89CoN13O15P · HCl  
MW   1382.82 g/mol 
Purity   96% 
Imidazol   
Brand   Carl ROTH® 
Formula   C3H4N2 
MW   68.08 g/mol 
Purity   99% 
IPTG  Brand   Brand    
Sigma-Aldrich ®  
Formula   C9H18O5S 
MW   238.30 g/mol 
Purity   99% 
Methylcobalamin  
Brand   Sigma-Aldrich ®  
Formula 
C63H91CoN13O14P  
MW   1344.38 g/mol 
Purity   97 % 
PEG 400   
Brand   Carl ROTH® 
Formula   NA 
MW   380-420 g/mol  
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S-adenosylcobalamin 
Brand   Sigma-Aldrich ®  
Formula  
C72H100CoN18O17P  
MW   1579.58 g/mol 
Purity    ≥97% 
Sodium cacodylate    
Brand   Sigma-Aldrich ®  
Formula   (CH3)2AsO2Na · 3H2O  
MW 214.03 g/mol  
Sodium chloride    
Brand   Merck Millipore® 
Formula   NaCl 
MW   58.44 g/mol 
Purity   NA  
Sodium hydroxide  
Brand   Brand   Carl ROTH® 
Formula   NaOH  
MW 40.01 g/mol 
Purity   44 – 46% 
Sodium L-ascorbate 
Brand   Sigma-Aldrich ®  
Formula   C6H7NaO6  
MW   198.11 g/mol 
Purity    ≥97% 
 
 
5.2.4 Columns 
● HisTrap HP column, 5ml Ni Sepharose (GE Healthcare) 
● Superdex 75 10/300 GL (GE Healthcare) 
● Superdex 200 10/300 GL (GE Healthcare) 
● His GraviTrap™ (GE Healthcare) 
● Sephadex G-25 in PD-10 Desalting Columns (GE Healthcare) 
● illustra™ NAP™ Columns, NAP-5 (GE Healthcare) 
 
5.2.5  Enzymes  
● FastAP (Fermentas/Thermo Scientific) 
● FD NdeI (Fermentas/Thermo Scientific) 
● FD XhoI (Fermentas/Thermo Scientific) 
● Q5 High fidelity DNA Polymerase (New England Biolabs) 
● Taq polymerase (Fermentas/Thermo Scientific) 
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● T4 ligase (New England Biolabs) 
● DNase I, RNase-free (Thermo Scientific) 
● Alkaline phosphatase (Fermentas) 
 
5.2.6 Kits 
● Molecular weight calibration kit for gel filtration (GE Healthcare) 
● Molecular weight calibration kit for SDS-PAGE (GE Healthcare)  
● Miniprep kit (Quiagen) 
● PCR-purification/Gel extraction kit (Quiagen) 
● Protease inhibitors (SERVA) 
● QIAGEN crystallization screenings 
○ Classics I Suite 
○ Classics II Suite 
○ PEGs I Suite 
○ PEGs II Suite 
○ JCSG+ Suite 
○ PACT Suite 
○ ProComplex Suite 
 
5.2.7 Miscellaneous  
● Amicon Ultra-15ml and 50ml (Millipore) 
● Dialysis membranes 3.5 kDa with glycerol (Spectra/Pore®) 
● Gene ruler 50bp (Fermentas/Thermo Scientific)  
● Gene ruler 100bp (Fermentas/Thermo Scientific)  
● Gene ruler 1kbp (Fermentas/Thermo Scientific)  
● Loading dye (6x) for DNA electrophoresis (Fermentas/Thermo 
Scientific)  
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5.3 Oligonucleotide sequences 
5.3.1 Chapter 2 
 
Name Sequence 
OT10_U3Spa_Cter_fwd  
ATATCGCATATGGATCCGAAAGTGCTGATCATG
CGCG 
OT10_U3Spa_Cter_rev  AATCTCGAGGGCGGCGCTCGT 
OT10_U3Spa_Cter_FA_del_rev CGGCCGGATAGTCGAGTGGCAGGTA 
OT10_U3Spa_Cter_FB_del_fwd TACCTGCCACTCGACTATCCGGCCG 
 
5.3.2 Chapter 3 
 
OT02_MCoAM_A_fwd  ATATCGCATATGCGTCGTCGTTATAAAGTT 
OT02_MCoAM_A_rev ATAAAACAGGGATCAAAACAACTTCAAAACCT 
OT02_UShs_B_fwd AGGTTTTGAAGTTGTTTTGATCCCTGTTTTA 
OT02_UShs_B_rev CCATTGCAACGTTCCCTTGGATT 
OT02_MCoA_C_rev  AATCTCGAGTGCTTCTGCTTCTTCAC 
OT02_MCoAM_C_fwd CCAAGGGAACGTTGCAATGGCA 
OT05_Q198A_UShsMMap01_fwd  ATCGCAGGGAACATAGTAAGAGCT 
OT05_Q198A_UShsMMap01_rev AGCTCTTACTATGTTCCCTGCGAT 
OT12_UShsMMap_L225Y_fwd CAT CTG CAT TAT ATG AAA CGT 
OT12_UShsMMap_L225Y_rev ACG TTT CAT ATA ATG CAG ATG 
OT16_UShsMMap_hcap_fwd 
CAGACACCGGAACAGGTTGCAATGGCAGCAGTT
CAAGAG 
OT16_UShsMMap_hcap_rev 
CTGTTCCGGTGTCTGTGGGTGTGCAACTGTCTG
ATACAC 
OT17_UShsMMap_G196A_fwd GTTGCACACCCAGCAATCGCAGGGAACGTT 
OT17_UShsMMap_G196A_rev AACGTTCCCTGCGATTGCTGGGTGTGCAAC 
OT18_UShsMMap_G196E_fwd GTTGCACACCCAGAAATCGCAGGGAACGTT 
OT18_UShsMMap_G196E_rev AACGTTCCCTGCGATTTCTGGGTGTGCAAC 
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5.3.1 Chapter 4 
 
Name Sequence 
OT15_UShsMMap_H17A_fwd TCTGGATGGTGCTGATCGTGGT 
OT15_UShsMMap_H17A_rev ACCACGATCAGCACCATCCAGA 
OT27_U3Shs_S84H_fwd ATTTTTACCCACCCCAGAGCAGTG 
OT27_U3Shs_i84H_fwd ATTTTTACCCACAGCCCCAGAGCAGTG 
OT27_U3Shs_rev GAGTCCCCCGTAATCTTCAGG 
OT28_U3Shs_G121H_fwd TATGTGGTTCACAATGCTACTGCTT 
OT28_U3Shs_G121H_rev CACTGACTTGGCATTCCATTTTTCTTT 
OT29_U3Shs_i141H_fwd GAAACCTGTCACAATGCAGAAAAG 
OT29_U3Shs_ rev TCCTTCTGTATCCAGGCCAATTTT 
OT30_U3Shs_i165H_fwd CTATTTCCCTGTCATGGAAACCTCAAAAG 
OT30_U3Shs_r AAGAGGCAGTGCTGAGGA 
 
5.4  Protein sequences 
5.4.1 Sequences corresponding to Chapter 2 
  
U3S half variants for experimental characterization 
cU3S 
 
 
 
 
cU3SΔ 
MDPKVLIMRGEGGREFLAERLRGQGVQVDYLPLYRRRAPDYPA
GELLARVRAERLNGLVVSSGQGLQNLYQLAAADWPEIGRLPLF
VPSPRVAEMARELGAQRVIDCRGASAPALLAALTSAALEHHHH
HH 
 
MDPKVLIMRGEGGREFLAERLRGQGVQVDYLPL------DYPA 
GELLARVRAERLNGLVVSSGQGLQNLYQLAAADWPEIGRLPLF
VPSPRVAEMARELGAQRVIDCRGASAPALLAALTSAALEHHHH
HH 
U3S full-length sequences 
1jr2  
 
 
 
 
 
 
 
4es6 
 
MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSL
PSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERS
LKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYI
CSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVA
HPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDN
IDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKA
LQ 
 
MSGWRLLLTRPDEECAALAASLGEAGVHSSSLPLLAIDPLEET
PEQRTLMLDLDRYCAVVVVSKPAARLGLERLDRYWPQPPQQTW
 89 
 
 
 
 
 
3re1 
 
 
 
 
 
 
3d8r 
 
 
 
 
 
 
1wcw 
 
 
 
 
 
 
 
3mw8 
 
 
 
CSVGAATAAILEAYGLDVTYPEQGDDSEALLALPAFQDSLRVH
DPKVLIMRGEGGREFLAERLRGQGVQVDYLPLYRRRAPDYPAG
ELLARVRAERLNGLVVSSGQGLQNLYQLAAADWPEIGRLPLFV
PSPRVAEMARELGAQRVIDCRGASAPALLAALTSAA 
 
MSAWRLLLTRPAEESAALARVLADAGIFSSSLPLLETEPLPLT
PAQRSIIFELLNYSAVIVVSKPAARLAIELIDEVWPQPPMQPW
FSVGSATGQILLDYGLDASWPEQGDDSEALLDHPRLKQAIAVP
GSRVLIMRGNEGRELLAEQLRERGVGVDYLPLYRRYLPQHAPG
TLLQRVEVERLNGLVVSSGQGFEHLLQLAGDSWPDLAGLPLFV
PSPRVASLAQAAGARNVIDCRGASAAALLAALRDQPQPAVKAY 
 
MRIAYAGLRRKEEFKALAEKLGFTPLLFPVQATEKVPVPEYRD
QVRELAQGVDLFLATTGVGVRDLLEAGKALGLDLEGPLAKAFR
LARGAKAARALKEAGLPPHAVGDGTSKSLLPLLPQGRGVAALQ
LYGKPLPLLENALAERGYRVLPLMPYRHLPDPEGILRLEEAVL
RGEVDALAFVAAIQVEFLFEGAKDPKALREALNTRVKALAVGR
VTADALREWGVKPFYVDETERLGSLLQGFKRALQKEVA 
 
MRRLEEDAVRVAYAGLRRKEAFKALAEKLGFTPLLFPVQATEK
VPVPEYRDQVRALAQGVDLFLATTGVGVRDLLEAGKALGLDLE
GPLAKAFRLARGAKAARALKEAGLPPHAVGDGTSKSLLPLLPQ
GRGVAALQLYGKPLPLLENALAERGYRVLPLMPYRHLPDPEGI
LRLEEALLRGEVDALAFVAAIQVEFLFEGAKDPKALREALNTR
VKALAVGRVTADALREWGVKPFYVDETERLGSLLQGFKRALQK
EVA 
 
MKLLLTRPEGKNAAMASALDALAIPYLVEPLLSVEAAAVTQAQ
LDELSRADILIFISTSAVSFATPWLKDQWPKATYYAVGDATAD
ALALQGITAERSPADSQATEGLLTLPSLEQVSGKQIVIVRGKG
GREAMADGLRLRGANVSYLEVYQRACPPLDAPASVSRWQSFGI
DTIVVTSGEVLENLINLVPKDSFAWLRDCHIIVPSARVETQAR
KKGLRRVTNAGAANQAAVLDALGM 
U3S N-terminal halves 
1jr2_nter 
 
 
 
 
4es6_nter 
 
 
 
3re1_nter 
 
 
 
1wcw_nter 
 
 
 
MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSL
PSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERS
LKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYI
CSRES 
 
MSGWRLLLTRPDEECAALAASLGEAGVHSSSLPLLAIDPLEET
PEQRTLMLDLDRYCAVVVVSKPAARLGLERLDRYWPQPPQQTW
CSVGAATAAILEAYGLDVTYPEQGDDSEALLALPAFQDSLRV 
 
MSAWRLLLTRPAEESAALARVLADAGIFSSSLPLLETEPLPLT
PAQRSIIFELLNYSAVIVVSKPAARLAIELIDEVWPQPPMQPW
FSVGSATGQILLDYGLDASWPEQGDDSEALLDHPRLKQAIAV 
 
MRRLEEDAVRVAYAGLRRKEAFKALAEKLGFTPLLFPVQATEK
VPVPEYRDQVRALAQGVDLFLATTGVGVRDLLEAGKALGLDLE
GPLAKAFRLARGAKAARALKEAGLPPHAVGDGTSKSLLPLLPQ
G 
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3mw8_nter 
 
 
 
3d8r_nter 
MKLLLTRPEGKNAAMASALDALAIPYLVEPLLSVEAAAVTQAQ
LDELSRADILIFISTSAVSFATPWLKDQWPKATYYAVGDATAD
ALALQGITAERSPADSQATEGLLTLPSLEQVS 
 
MRIAYAGLRRKEEFKALAEKLGFTPLLFPVQATEKVPVPEYRD
QVRELAQGVDLFLATTGVGVRDLLEAGKALGLDLEGPLAKAFR
LARGAKAARALKEAGLPPHAVGDGTSKSLLPLLPQG 
U3S C-terminal halves 
1jr2_cter 
 
 
 
4es6_cter 
 
 
 
3re1_cter 
 
 
 
 
1wcw_cter 
 
 
 
 
3mw8_cter 
 
 
 
3d8r_cter 
SALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQ
GNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIK
FAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQ 
 
HDPKVLIMRGEGGREFLAERLRGQGVQVDYLPLYRRRAPDYPA
GELLARVRAERLNGLVVSSGQGLQNLYQLAAADWPEIGRLPLF
VPSPRVAEMARELGAQRVIDCRGASAPALLAALTSAA 
 
PGSRVLIMRGNEGRELLAEQLRERGVGVDYLPLYRRYLPQHAP
GTLLQRVEVERLNGLVVSSGQGFEHLLQLAGDSWPDLAGLPLF
VPSPRVASLAQAAGARNVIDCRGASAAALLAALRDQPQPAVKA
Y 
 
RGVAALQLYGKPLPLLENALAERGYRVLPLMPYRHLPDPEGIL
RLEEALLRGEVDALAFVAAIQVEFLFEGAKDPKALREALNTRV
KALAVGRVTADALREWGVKPFYVDETERLGSLLQGFKRALQKE
VA 
 
GKQIVIVRGKGGREAMADGLRLRGANVSYLEVYQRACPPLDAP
ASVSRWQSFGIDTIVVTSGEVLENLINLVPKDSFAWLRDCHII
VPSARVETQARKKGLRRVTNAGAANQAAVLDALGM 
 
RGVAALQLYGKPLPLLENALAERGYRVLPLMPYRHLPDPEGIL
RLEEAVLRGEVDALAFVAAIQVEFLFEGAKDPKALREALNTRV
KALAVGRVTADALREWGVKPFYVDETERLGSLLQGFKRALQKE
VA 
U3S permuted variants according to the protein lobes 
1jr2_L1 
 
 
 
 
4es6_L1 
 
 
 
3re1_L1 
 
 
 
 
1wcw_L1 
MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSSITVYQ
TVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELS
GDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGI
RKALQ 
 
MSGWRLLLTRPDEECAALAASLGEAGVHSSSLPLLAIRRAPDY
PAGELLARVRAERLNGLVVSSGQGLQNLYQLAAADWPEIGRLP
LFVPSPRVAEMARELGAQRVIDCRGASAPALLAALTSAA 
 
MSAWRLLLTRPAEESAALARVLADAGIFSSSLPLLETRYLPQH
APGTLLQRVEVERLNGLVVSSGQGFEHLLQLAGDSWPDLAGLP
LFVPSPRVASLAQAAGARNVIDCRGASAAALLAALRDQPQPAV
KAY 
 
MRRLEEDAVRVAYAGLRRKEAFKALAEKLGFTPLLFPVQATHL
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3mw8_L1 
 
 
 
3d8r_L1 
 
 
 
 
1jr2_L2 
 
 
 
 
4es6_L2 
 
 
 
3re1_L2 
 
 
 
 
1wcw_L2 
 
 
 
3mw8_L2 
 
 
 
3d8r_L2 
PDPEGILRLEEALLRGEVDALAFVAAIQVEFLFEGAKDPKALR
EALNTRVKALAVGRVTADALREWGVKPFYVDETERLGSLLQGF
KRALQKEVA 
 
MKLLLTRPEGKNAAMASALDALAIPYLVEPLLSVRACPPLDAP
ASVSRWQSFGIDTIVVTSGEVLENLINLVPKDSFAWLRDCHII
VPSARVETQARKKGLRRVTNAGAANQAAVLDALGM 
 
MRIAYAGLRRKEEFKALAEKLGFTPLLFPVQATEHLPDPEGIL
RLEEAVLRGEVDALAFVAAIQVEFLFEGAKDPKALREALNTRV
KALAVGRVTADALREWGVKPFYVDETERLGSLLQGFKRALQKE
VA 
 
FEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKT
EVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAE
KLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESIT
VYQT 
 
IDPLEETPEQRTLMLDLDRYCAVVVVSKPAARLGLERLDRYWP
QPPQQTWCSVGAATAAILEAYGLDVTYPEQGDDSEALLALPAF
QDSLRVHDPKVLIMRGEGGREFLAERLRGQGVQVDYLPLYR 
 
EPLPLTPAQRSIIFELLNYSAVIVVSKPAARLAIELIDEVWPQ
PPMQPWFSVGSATGQILLDYGLDASWPEQGDDSEALLDHPRLK
QAIAVPGSRVLIMRGNEGRELLAEQLRERGVGVDYLPLYRRYL
PQHA 
 
TEKVPVPEYRDQVRALAQGVDLFLATTGVGVRDLLEAGKALGL
DLEGPLAKAFRLARGAKAARALKEAGLPPHAVGDGTSKSLLPL
LPQGRGVAALQLYGKPLPLLENALAERGYRVLPLMPYRH 
 
EAAAVTQAQLDELSRADILIFISTSAVSFATPWLKDQWPKATY
YAVGDATADALALQGITAERSPADSQATEGLLTLPSLEQVSGK
QIVIVRGKGGREAMADGLRLRGANVSYLEVY 
 
KVPVPEYRDQVRELAQGVDLFLATTGVGVRDLLEAGKALGLDL
EGPLAKAFRLARGAKAARALKEAGLPPHAVGDGTSKSLLPLLP
QGRGVAALQLYGKPLPLLENALAERGYRVLPLMPYR 
U3S permuted variants (ɑβɑ-swaps permuted) 
1jr2-Cɑβɑ 
 
 
 
 
1wcw-Cɑβɑ 
 
 
 
3d8r-Cɑβɑ 
 
 
SALPLLFPCGNLKREILPKALKDKGIAMESITVYQTFEFLSLP
SFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSL
KEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYIC
SRES 
 
RGVAALQLYGKPLPLLENALAETEKVPVPEYRDQVRALAQGVD
LFLATTGVGVRDLLEAGKALGLDLEGPLAKAFRLARGAKAARA
LKEAGLPPHAVGDGTSKSLLPLLPQG 
 
RGVAALQLYGKPLPLLENALAERGYRVLPLMPYRKVPVPEYRD
QVRELAQGVDLFLATTGVGVRDLLEAGKALGLDLEGPLAKAFR
LARGAKAARALKEAGLPPHAVGDGTSKSLLPLLPQG 
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3mw8-Cɑβɑ 
 
 
 
3re1-Cɑβɑ 
 
 
 
4es6-Cɑβɑ 
GKQIVIVRGKGGREA?ADGLRLRGANVSYLEVYQRACPEAAAV
TQAQLDELSRADILIFISTSAVSFATPWLKDQWPKATYYAVGD
ATADALALQGITAERSPADSQATEGLLTLPSLEQVS 
 
PGSRVLIMRGNEGRELLAEQLRERGVGVDYLPLYRRYEPLPLT
PAQRSIIFELLNYSAVIVVSKPAARLAIELIDEVWPQPPMQPW
FSVGSATGQILLDYGLDASWPEQGDDSEALLDHPRLKQAIAV 
 
HDPKVLIMRGEGGREFLAERLRGQGVQVDYLPLYRIDPLEETP
EQRTLMLDLDRYCAVVVVSKPAARLGLERLDRYWPQPPQQTWC
SVGAATAAILEAYGLDVTYPEQGDDSEALLALPAFQDSLRV 
 
5.4.2 Sequences corresponding to Chapter 3 
  
MCoAMap  RRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVYTGLRQTP
EQVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLRELGADDI
PVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKVRKLAE
EKRMREEAEAHHHHHH 
UShsMMap01 
 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSF
EFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTE
VWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEK
LAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITV
YQTVAHPGIQGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMA
KLRELGADDIPVVLGGTIPIPDLEPLRSLSIREIFLPGTSLGE
IIEKVRKLAEEKRMREEAEALEHHHHHH 
UShsMMap02 
(UShsMMap01_Q198A) 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSF
EFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTE
VWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEK
LAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITV
YQTVAHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMA
KLRELGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGE
IIEKVRKLAEEKRMREEAEALEHHHHHH 
UShsMMap03 
(UShsMMap02_L225Y) 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSF
EFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTE
VWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEK
LAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITV
YQTVAHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMA
KLRELGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGE
IIEKVRKLAEEKRMREEAEALEHHHHHH 
 
UShsMMap04 
(UShsMMap02_G196A) 
 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSF
EFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTE
VWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEK
LAEYICSRESSALPLLFPCGNLKREILPKALKDKAIAMESITV
YQTVAHPAIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMA
KLRELGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGE
IIEKVRKLAEEKRMREEAEALEHHHHHH 
UShsMMap05 MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSF
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(UShsMMap02_G196E) 
 
EFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTE
VWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEK
LAEYICSRESSALPLLFPCGNLKREILPKALKDKAIAMESITV
YQTVAHPEIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMA
KLRELGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGE
IIEKVRKLAEEKRMREEAEALEHHHHHH 
UShsMMap06 
(UShsMMap02_HCap) 
 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSF
EFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTE
VWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEK
LAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITV
YQTVAHPTPEQVAMANAVQEDVDVIGVSILNGAHLHLMKRLMA
KLRELGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGE
IIEKVRKLAEEKRMREEAEALEHHHHHH 
 
5.4.3 Sequences corresponding to Chapter 4 
 
UShsMMap02_H17A MRRRYKVLVAKMGLDGADRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVW
ERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAE
YICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTV
AHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLREL
GADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKVR
KLAEEKRMREEAEALEHHHHHH 
UShsMMap02_G121H MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVW
ERSLKEKWNAKSVYVVHNATASLVSKIGLDTEGETCGNAEKLAE
YICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTV
AHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLREL
GADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKVR
KLAEEKRMREEAEALEHHHHHH 
UShsMMap02_S84H MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTHPRAVEAAELCLEQNNKTEVW
ERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAE
YICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTV
AHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLREL
GADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKVR
KLAEEKRMREEAEALEHHHHHH 
UShsMMap02_i141H 
(insertion before 
G141) 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVW
ERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCHGNAEKLA
EYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQT
VAHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLRE
LGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKV
RKLAEEKRMREEAEALEHHHHHH 
UShsMMap02_i165H 
(insertion before 
G165) 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVW
ERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAE
YICSRESSALPLLFPCHGNLKREILPKALKDKGIAMESITVYQT
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VAHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLRE
LGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKV
RKLAEEKRMREEAEALEHHHHHH 
UShsMMap02_i84H 
(ins before S63) 
MRRRYKVLVAKMGLDGHDRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTHSPRAVEAAELCLEQNNKTEV
WERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLA
EYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQT
VAHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLRE
LGADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKV
RKLAEEKRMREEAEALEHHHHHH 
UShsMMap02_H17C MRRRYKVLVAKMGLDGCDRGAKVVARALRDAGFEVVLIPVLSFE
FLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVW
ERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAE
YICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTV
AHPGIAGNVAMAAVQEDVDVIGVSILNGAHLHLMKRLMAKLREL
GADDIPVVLGGTIPIPDLEPLRSLGIREIFLPGTSLGEIIEKVR
KLAEEKRMREEAEALEHHHHHH 
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5.5  Vectors 
 
5.5.1  13AN6UP_MMcM_pMA 
 
This vector codes for the cobalamin-binding subunit of methylmalonyl-CoA mutase 
(MCoAMap) (Section 2.9.1). The gene was synthesized by Life Technologies and cloned into 
a pMA vector, employing the KpnI and SacI cloning sites. The plasmid bears ampicillin 
resistance. 
 
 
 
Figure 5.1 Plasmid DNA 13AAN6UP_MMcM_pMA. This vector contains the methylmalonyl-CoA 
mutase gene from Aeropyrum pernix. 
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5.5.2  pET21a(+) Novagen® ampicillin resistance 
 
pET-21(+) is a transcription vector designed for expression from bacterial translation signals 
carried within a cloned insert. Generated genes in this work were clones into this vector 
employing NdeI and XhoI restriction sites.  
 
 
Figure 5.2 Expression vector pET-21a(+) 5. This vector was employed to clone all the constructs created for 
this doctoral work employing restriction sites NdeI and XhoI.  
 
5 Adapted from https://www.addgene.org/12604/ 
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5.5.3 pET16b(+) Novagen®  ampicillin resistance.  
 
The gene coding for the uroporphyrinogen III synthase from human was contained in this 
vector pET16b-U3S and has been described in the literature (Mathews 2001). This construct 
was kindly handed out by Prof. Heidi L. Schubert.  
 
 
Figure 5.3 Expression vector pET-16b(+)6. This vectors contained the uroporphyrinogen III synthase from 
human described in Chapter 3. 
  
 
6 Adapted from http://www.biofeng.com/zaiti/dachang/pet16b.html 
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5.5.4 pET28a(+)  Novagen® ampicillin resistance 
 
The pET-28a-c(+) vector carries an N-terminal His•Tag®/thrombin/T7•Tag® configuration in 
addition to an optional C-terminal His•Tag sequence. Restriction sites are shown on the circle 
map. In this vector, the T7 expression region is reversed on the circular map. Construct 
PA5259 (Moynie et al. 2013) employed for the amplification of ctU3S and ctU3SΔ (Chapter 
2) was contained in this vector and was kindly handed out by Prof. Gunter Schneider and Dr. 
Robert Schnell. 
 
 
Figure 5.4 Expression vector pET-28a(+) vector map by Novagen7.   
 
 
 
7 Adapted from (https://biochem.web.utah.edu/hill/links/pET28.pdf) 
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5.6  Software 
● Ape-A Plasmid Editor (M. Wayne Davis) 
● PyMOL (Molecular Graphics System, Version 1.7 and 2.0 Schrödinger, 
LLC. 
● LigPlot+ 
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Chapter 6 
Methods  
 
6.1. Bioinformatics 
 
6.1.1. Sequence-based profile-profile comparisons with HHsearch 
 
To generate sequence-based Hidden-Markov-Models, we first built multiple sequence 
alignments for all domains of the ɑ/β-class contained in the astral database release 2.07 
(Chandonia, Fox, and Brenner 2019). The alignments were generated employing PSI-BLAST 
(Altschul 1997), which is a program included in the build.pl protocol described elsewhere 
(Söding 2005). This program was used to generate the profile-profile comparisons with 
default parameters. The secondary structure prediction was turned off (ssm=0) in order to 
perform a strictly sequence-based search. The gathered homologous regions were aligned 
with TM-align (Y. Zhang and Skolnick 2005). The obtained alignments were parsed and 
stored in a spreadsheet-based pivot table for further pair selection according to sequence 
identity and probability scores. 
6.1.2. Structural alignments 
 
Structural alignments of individual candidates were assessed with PDBeFold (Krissinel and 
Henrick 2004), an online server for secondary-structure matching. In cases where only a part 
of the pdb structure was needed, the corresponding pdb coordinates were extracted manually 
employing The PyMOL Molecular Graphics System (by Schrödinger, LLC). 
 
6.1.3.  Construction of a U3S database of protein halves 
 
All U3S sequences with known structure were trimmed manually in half. Hereby, the cutsites 
were defined by eye, cutting in loop regions in the protein middle. N- and C-terminal regions 
kept exactly the same secondary structural elements.  
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6.1.4.  Construction of a U3S dataset of permuted protein halves 
 
Three different permuted variants were generated. Two of them by trimming the lower and 
upper lobes of U3S proteins, similar to the CATH domain assignment, but ignoring the 
connecting beta sheets between the lobes. Lower lobes were named as their pdb identifiers 
followed by the ending “_L1” for lower and “_L2” for upper lobes, e.g., 1jr2_L1 and 1jr2_L2 
(Section 5.4.1). An additional variant can be generated by appending the N-terminal ɑβɑ-
swap to the C-termini. These variants were named after their corresponding pdb identifiers 
followed by “_Cɑβɑ”, e.g, 1jr2_Cɑβɑ (Section 5.4.1).  
 
6.2. Cloning  
 
6.2.1. Gene assembly of U3S and U3SΔ by PCR (Chapter). 
 
The C-terminal half of the U3S (cU3S) gene from Pseudomonas aeruginosa was amplified by 
PCR, employing primers OT10_U3Spa_Cter_fwd and OT10_U3Spa_Cter_rev (Section 
5.3.1), and PA5259 as template. PA5259 has been described elsewhere (Moynie et al. 2013) 
and was kindly handed out by Prof. Gunter Schneider and Dr. Robert Schnell. To delete the 
six amino acid insertion, two fragments A and B were amplified from cU3S employing the 
previously mentioned outer primers and adequate oligos (OT10_U3Spa_Cter_FA_del_rev 
and OT10_U3Spa_Cter_FB_del_fwd, respectively, Section 5.4.1), which flank the region to 
be deleted, creating instead sticky ends for a further annealing in a last PCR reaction. To 
finally assemble cU3SΔ, fragments A and B were mixed and amplified using the outer 
primers employed for cU3S. The assembled genes were cloned into a pET21a expression 
vector, yielding pET21a-cU3S and pET21a-cU3SΔ, respectively. 
 
6.1.2. Gene assembly of chimeric hybrid UShsMMap01 (Chapter 3) 
 
The chimeric gene was assembled in two steps as shown in Figure 3.5. Hereby, three flanking 
fragments termed A, B and C were amplified employing the parental gene corresponding to 
the cobalamin-binding subunit of Methylmalonyl-CoA mutase (MCoAM) from Aeropyrum 
pernix (Section 5.5.1). The middle fragment B, was amplified from pET16b-U3S described 
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elsewhere (Moynie et al. 2013), employing for each PCR reaction corresponding 
oligonucleotides as shown below: 
Fragment A: OT02_MCoA_A_fwd and OT02_MCoA_A_rev (Section 5.3.1) 
Fragment B: OT02_UShs_B_fwd and OT02_UShs_B_rev (Section 5.3.1) 
Fragment C: OT02_MCoA_C_fwd and OT02_McoA_C_rev (Section 5.3.1 
 
6.1.3. PCR reaction conditions 
 
Vol. [µl] Reagent Stock conc. 
5x 
10 mM 
100 ng/µl 
10 µM 
10 µM 
2 u/µl 
 
Final conc 
1x 
0.8 mM 
50 ng 
0.5 µM 
0.5 µM 
1 u 
 
10.0 
4.0 
0.5 
2.5 
2.5 
1.0 
29.5 
Q5 Buffer 
dNTPs (Eurogene®) 
Template 
Forward primer 
Reverse primer 
Q5 DNA polymerase 
 H2O 
 
Temperature Cycles Time 
98℃ 1x 5 min 
98℃ 
MT + 3°C 
72℃ 
30x 
 
30 sec 
30 sec 
120 sec 
72℃ 1x 5 min 
4℃  ∞  
   
 
6.1.4. Directed mutagenesis (Quick change) 
 
 
Site-directed mutagenesis was carried out to insert a single mutation employing a method 
described elsewhere (Ho et al. 1989). The obtained products were purified with the Qiagen 
PCR purification method according to the manufacturer protocol before digestion with 
adequate restriction enzymes.  
 
 
 
 
 103 
6.2. Molecular methods for purification  
 
6.2.2. Gel electrophoresis 
      
All PCR products and digested vectors were mixed with a DNA-loading dye (Thermo 
scientific) and loaded onto a 1% agarose gel. DNA containing mixtures were carefully 
deposited into the gel pockets. A current of 70V was applied to the chamber to separate the 
PCR products. Running times varied depending on the size of the fragments. As running 
buffer TAE-buffer (Section 5.2.2.1) was employed. 
 
6.2.3. DNA purification by gel extraction 
 
PCR products and digested fragments were loaded onto an agarose gel (1%) for gel 
electrophoresis. The gel was observed under a UV lamp ECX-20M (Peqlab) to make the 
DNA-bands visible. Desired bands were extracted with a sterile cutter and deposited into a 1.5 
ml Eppendorf® tube. Purification of the amplified fragments was performed according to the 
recommended protocol QIAquick gel extraction kit of QIAGEN® Handbook 2011. Elution 
volumes ranged from 35 to 50µl  depending on the intensity of the bands. 
      
6.3. DNA digestion with restriction enzymes 
 
Digestion of DNA fragments and vectors was performed using XhoI and NdeI (Thermo 
Scientific) restriction enzymes. All digestion samples were incubated at 37°C for 30 minutes 
using the following reaction mix: 
 
Volume in [µl] 
5 
1 
1 
5 
38 
50.00 (final vol.) 
Component 
Universal Buffer 
NdeI 100% activity 
XhoI 100% activity 
fragment 
H2O 
Concentration 
10x 
10u/µl 
10u/µl 
50 ng/ 
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6.4. Vector dephosphorylation  
 
To avoid vetor self-ligation, all digested vectors were phosphorylated directly after digestion 
without purifying the sample, by adding 1 µl of alkaline phosphatase (Fermentas) and 
incubating for 1 hour at 37°C. 
 
6.5. DNA ligation with T4 DNA-ligase 
 
The ligation of digested DNA fragments was performed using the T4 DNA-ligase from NE 
BioLabs®. All samples were incubated at 4°C for 24 hours and stored at -20°C if not used 
immediately after ligation. Different vector/insert molar ratios were tried (commonly 1 to 2, 4 
and 6, respectively). The concentration of the digested vector was always 60 ng in 20 µl 
reaction volume.  
 
6.6. Transformation of chemically competent cells 
 
Three different chemically competent cells were employed: Top10TM, BL21 and 
ArtictExpressTM. All were prepared according to standard protocols (Dagert and Ehrlich 
1979) and stored in 100 µl aliquots in 1.5 ml Eppendorf® tubes at -80°C until further usage. 
Competent cells were thawed on ice previous to addition of DNA. 50 ng of a plasmid solution 
or 10µl of a ligation reaction were added to the cells and incubated on ice for 15 min. A heat 
shock step was performed (45 seconds for Top10 and BL21 and 22 seconds for 
ArticExpressTM) and incubated on ice for 15 min. 800 µl of LB medium (Section 5.2.2.2) 
were added to the cells for further incubation at 37°C for 1 hour. During this time, samples 
were shakenat 600 rpm using an Eppendorf® thermomixer model No.5436. After the 
incubation time transformed cells coming from ligation attempts were centrifuged at 4000 
rpm using an Eppendorf® bench centrifuge model No.5425 for 5 min. Pellets were 
resuspended in 200 µl LB medium for their subsequent plating on agar Petri dishes with 
adequate antibiotics. Petri dishes were incubated at 37°C overnight or for 72 hours at room 
temperature. 
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6.7. Plasmid extraction 
 
5 ml LB medium (Section 5.2.2.2) were inoculated with a single colony coming from 
Top10TM transformation and incubated overnight at 37°C. The extraction of the supercoiled 
DNA-plasmids from the cell culture was performed according to the recommended protocol 
of QIAGEN® Plasmid Mini Kit. Handbook 2011. Elution volumes ranged from 35 to 50µl. 
 
6.8. Colony PCR 
 
A screening for properly ligated target genes was assessed directly from freshly transformed 
colonies via PCR amplification. Single colonies were picked and added to the PCR-mix 
(Section 6.2.3) using Taq-polymerase (Fermentas/Thermo Scientific). T7prom and T7ter 
oligonucleotides were employed as primers for the amplification. Resulting products were 
analysed by agarose gel electrophoresis. 
      
6.9. DNA Sequencing 
 
Vectors mentioned in this work were sequenced by the sequencing facility of the Max Planck 
Institute for Developmental Biology in Tuebingen or Eurofins Laboratory Scientific 
employing 50 ng of pure target DNA. In house sequencing required a manual sequencing 
reaction. Thus, 50 ng of DNA template were mixed with 2 µl of sequencing buffer, 0.5µl of 
BDT mix and the corresponding oligonucleotide to reach final concentration of 1µM. Water 
was added to a volume of 10µl and the reaction was set on a thermocycler employing the 
following sequencing program:  
 
 
96◦C  20 sec  
50◦C  10 sec      (30 cycles) 
60◦C  4 min     
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6.10. Test expression 
 
An expression test was carried out to check solubility of modified proteins before scaling up  
expression. 15 ml of LB-medium were inoculated with freshly transformed colonies (either 
AEX or BL21) and incubated at 37°C until an optical density (OD600) of about 0.6 was 
reached. Immediately after the cell suspensions were split into two 50ml-flasks one of the cell 
solutions was induced with 1 mM final concentration IPTG and the other treated as a control 
to check for leaky expression. Special attention was paid to expression with AExpress. Once 
the cultures reached the optimal OD, they were cooled on ice to lower the temperature before 
addition of IPTG. Protein expression succeeded at 20°C (BL21) and 11-16°C (AExpress) 
overnight. Protein solubility was corroborated by Gel electrophoresis (Section 6.15.3) 
 
6.11. Protein expression 
 
Protein expression was usually performed in6 L batches.Single colonies resulting from 
plasmid transformation were employed to inoculate 50 ml LB medium enriched with 1 mM 
ampicillin and incubated at 37°C overnight. 10 ml of the starting culture were used to 
inoculate each 1 L TB medium (Section 5.2.2.2) enriched with 1 mM ampicillin and 
incubated at 37°C in 5L-sized flasks. As soon as an OD600 of ~0.4 was observed, the 
temperature of the incubator was reduced to 20°C. Expression of the protein was induced at 
~0.6 OD600 by adding 1 mM IPTG incubating further for ~ 16 hours before harvesting. If not 
employed immediately, pellets were stored at -20/-80°C. 
 
6.12. Cell disruption by sonication 
 
 
After expression cells from 3 L culture were centrifuged at 4000 rpm using an Avanti J-26xPI 
(Beckmann Coultier) centrifuge for 20 min. The resulting pellet was resuspended in 10 ml of 
Buffer-A. 100 µl of a protease inhibitor cocktail (SERVA) were added to avoid proteolysis. 
The cell suspension was disrupted by sonication with a Bandelin HD 3100 (Sonoplus) 
sonicator 3 times at 40% amplitude for 3 minutes. The lysate was centrifuged at 18000 rpm in 
an Avanti J-26xPI (Beckmann Coultier) centrifuge. 
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6.13. Refolding 
  
Protein refolding was usually performed from inclusion bodies coming from 1 L culture. If 
not mentioned otherwise all incubation steps were performed at 4°C. The inclusion bodies-
containing pellet was resuspended in 5 ml R1-buffer and incubated for at least 60 min. 5ml of 
R2-buffer were added to the previous mixture and mixed gently before further incubation for 
1h. After this time, the protein suspension was centrifuged at 18000 rpm for 60 min to remove 
membrane and other non-protein cell components. The resulting protein solution was mixed 
with R3-buffer to reach a final volume of 25 ml and dialyzed 2 times against 5 L of Buffer-
A. The resulting solution was centrifuged  at 18000 rpm and 4°C for 1 hours using an Avanti 
J-26xPI (Beckmann Coultier) centrifuge to separate soluble proteins from their aggregates. 
 
6.14.  Protein purification 
 
6.14.1. Nickel affinity chromatography 
 
Protein samples coming from lysate or refolding were passed through a 0.2um filter prior to 
injection onto a 5ml-nickel column HisTrap HPTM (GE Healthcare Life Sciences) previously 
equilibrated with 50 ml of Buffer-A. After loading the protein,  a wash step using 20 ml of 
buffer-A was performed. The elution of the target proteins succeeded with an imidazole 
linear gradient with Buffer-B.  
      
6.14.2.  Preparative Gel filtration 
 
Protein samples were passed through a 0.2 µm filter or centrifuged at 18 000 rpm for 15 min 
before injection. Preparative SuperdexTM columns S200 or S75 were equilibrated with 350 ml 
of GeFi-buffer. The protein sample was loaded and run at a constant flow rate of 1.5 ml/min. 
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6.15.  Protein analysis by gel electrophoresis 
 
To determine size and purity of a given protein, polyacrylamide gels (15%) were prepared. 
Protein samples were heated at 95°C for 5 min in the presence of denaturing SDS-buffer. 10 
to 15 µl of the denatured sample were carefully deposited in the gel pockets and subjected to 
70 mV for separation.  
 
6.16.  Biophysical characterization of proteins  
 
6.16.1.  Analytical gel filtration 
 
Prior to injection the protein sample was either filtered with a 0.2 µm filter or centrifuged at 
18 000 rpm using an Avanti J-26xPI (Beckmann Coultier) centrifuge. Analytical SuperdexTM 
columns S200 or S75 were equilibrated with 50 ml of GeFi-buffer (Section 5.2.7). After 
injecting the protein sample, a 25 ml run was performed at a constant flow rate of 0.5 ml/min. 
 
6.16.2.  Circular dichroism and thermal denaturation  
      
A pure protein sample was dialyzed overnight against CD-buffer to get rid of salts. 200µl of 
the dialyzed sample was adjusted to a concentration of 0.2 to 0.3 mg/ml and pipetted into a 
clean 1 mm quartz cuvette. Five instrumental replica were performed using a J-810 CD-
spectrometer (Jasco) with following parameters: 
 
Band width   1nm 
Response   2sec 
Sensitivity   standard 
Measurement range  190 - 240 nm 
Data pitch   0.1nm 
Scanning speed  100 nm/min  
Instrument replica  5 
      
The same sample used for CD measurements was employed for the thermal denaturation on 
the same instrument using the following parameters: 
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Band width   1nm 
Response   2sec 
Sensitivity   standard 
Measurement range  190 - 240 nm 
Data pitch   0.1nm 
Monitor wavelength  222nm 
Temperature slope  0.5°C 
 
The CD data in this work is reported in units of ellipticity and has been normalized for the 
molar concentration of the sample, employing the sample concentration, the cell pathlength, 
and the molecular weight.  
 
6.16.3.   Fluorescence  
      
A pure protein sample (usually the same employed for CD) was adjusted to a concentration of 
0.2 to 0.3 mg/ml and pipetted into a clean black fluorescence quartz cuvette with round 
bottom. Five instrumental replica were performed using a FP-6500 fluorescence-spectrometer 
(Jasco) with following parameters:  
 
Measurement mode  Emission spectrum 
Band width (ex)  3nm 
Band width (em)  3nm 
Response   0.2sec 
Sensitivity   medium 
Measurement range  300 - 400 nm 
Data pitch   0.2nm 
Excitation wavelength 280 nm 
Scanning speed   200 nm/min 
 
6.16.4.  UV-Vis spectrometry 
 
All measurements were carried out on a Cary 50 Scan UV-VIS spectrometer. Stock solutions 
for all cobalamins were prepared at 8 mM and diluted to 40 µM to take reference spectra, 
employing the corresponding buffer, depending on the measurement.   
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6.17.  Structure determination by X-ray crystallography 
 
6.17.1.  Crystal screening 
 
To screen for optimal conditions for crystallization 0.4 µl of a pure protein sample at 10 to 
12.5 mg/ml were mixed with the same volume of a screening buffer (Section 5.2.6) and 
deposited in  96-well plates via hanging drop method, employing a Mosquito crystallization 
robot. Screening plates were stored at 16°C or 4°C.  
 
6.17.2.  Crystal improvement 
 
Once crystals were obtained, the crystallization conditions were reproduced via hanging drop 
method, increasing the drop sized to 1 - 1.5 µl. In addition, the components of the screening 
buffer such as pH, salt concentration and precipitant concentration were varied in an attempt 
to improve crystal quality. All conditions were pipetted manually and all instruments needed 
were equilibrated at the desired incubation temperature before mixing with the protein 
sample. 
 
6.17.3.  Crystal handling and measurement 
 
Obtained crystals were fished with X-ray mounting loops in adequate sizes and cryoprotected 
in a solution of 30% v/v PEG 400. This was contained in the same crystal mother liquor. 
Fished crystals were finally cryocooled by plunging them into liquid nitrogen prior to data 
collection on the X10SA beamline at the Swiss Light Source, Paul Scherrer Institute (PSI) in 
Villingen Switzerland or the Berliner Elektronenspeicherring-Gesellschaft für 
Synchrotronstrahlung (BESSY). The data was collected at 100K and 0.5 oscillation degrees. 
The obtained images were recorded on a Pilatus 6M or a Pixel-detector Pilatus 2M at a  
distance of 270 nm and a wavelength of 1.000Å. The obtained reflexions were  indexed, 
integrated and scaled  with the XDS package (Kabsch 2010), employing 5% reflections for 
the test set.  
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6.17.4.  Crystal soaking with cobalamin derivatives 
 
Apo crystals grown in 0.1 M Tris at pH 5.7 and 15% PEG 4000 Were fished with appropriate 
crystal loops and deposited in a ligand solution with the same mother liquor for dilution. The 
concentration of the ligands varied according to Table 6.1. Soaking times ranged from 30 
minutes to 24 hours. The best soaking time was 3 hours. 
 
Table 6.1 soaking conditions with different cobalamin derivatives 
__________________________________________________________________________________________ 
Ligand Concentration 
Adenosylcobalamin, methylcobalamin, 
hydroxocobalamin and cyanocobalamin 
400 µM/ 4mM 
alpha-ribazole3-phosphate 10/20/40 mM 
dimethylbenzimidazole  20 mM (5% DMSO) 
_________________________________________________________________________ 
6.18. Structure determination with NMR (By Murray Coles and Manish 
Chaubey) 
 
2.9 mM of labelled cU3S∆ were contained in 50 mM KP and 150 mM KCl, 80% H2O/20% 
D2O  at pH 8. All spectra were recorded at 288 K on Bruker AVIII-600 and AVIII-800 
spectrometers. Backbone sequential assignments were completed using standard triple 
resonance experiments implemented using selective proton flip-back techniques for fast 
pulsing (Diercks, Daniels, and Kaptein 2005). Aliphatic side chain assignments were 
completed by a combination of CCH-COSY and CCH-TOCSY experiments, while aromatic 
assignments were made by linking aromatic spin systems to the respective CH2 protons in a 
2D-NOESY spectrum, combined with a PLUSH-TACSY experiment (Carlomagno et al. 
1996). Stereospecific assignments and the resulting rotamer assignments were determined 
from an HNHB experiment and NOESY cross-peak patterns. Distance data were derived from 
3D15N-HSQC NOESY and 3D-NNH-NOESY spectra on a 15N-labeled sample, and 3D13C-
HSQC-NOESY and 3D-CCH- and 3D-CNH-NOESY spectra (Diercks, Coles, and Kessler 
1999) on the 15N,13C-labeled sample. Aromatic contacts were observed in a 15N-filtered 2D-
NOESY spectrum. Structural restraints were compiled using a protocol aimed at high local 
accuracy using expectation NOESY spectra to test local conformational hypotheses (in-house 
software). Chemical shift similarity searches using TALOS (Cornilescu, Delaglio, and Bax 
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1999) were used to generate hypotheses for backbone conformations, while sidechain 
rotamers were searched exhaustively. Conformations identified in this manner were applied 
via dihedral restraints, using the TALOS-derived tolerances for backbone and ±30° for 
sidechains. Further NOE contacts were assigned iteratively using back-calculation of 
expectation NOESY spectra from preliminary structures. NOESY crosspeaks in the three-
dimensional spectra were converted into distance ranges after rescaling according to 
corresponding HSQC intensities. Crosspeaks were divided into four classes, which resulted in 
restraints on upper distances of 2.7, 3.2, 4.0 and 5.0 Å, respectively. Additional classes of 3.6 
and 4.5 Å were used for medium and weak backbone contacts often affected by spin-
diffusion. Lower distance restraints were included for very weak or absent sequential HN-HN 
crosspeaks using a minimum distance of 3.5 Å and medium intensity or weaker sequential 
and intraresidue HN-H# crosspeaks using a minimum distance of 2.7 Å. Allowances for the 
use of pseudoatoms (using averaging) were added for methyl groups and non-
stereospecifically assigned methylene groups. Hydrogen bond restraints were applied for 
residues in secondary structure where donor–acceptor pairs were consistently identified in 
preliminary calculations. The restraints were applied via inclusion of pseudo-covalent bonds 
between heavy atom acceptors and hydrogen donors, with force constants of 14 kcal/Å2 and 8 
kcal/rad2 on bond lengths and angles, respectively. Structures were calculated with XPLOR 
(NIH version 2.9.3 (C. Schwieters, Kuszewski, and Mariusclore 2006; C. D. Schwieters et al. 
2003)) using a three-stage simulated annealing protocol. The second stage included a 
conformational database potential, while the third used a relaxed force constant on peptide 
bond planarity. Sets of 50 structures were calculated and a final set of 20 chosen on the basis 
of lowest restraint violations. An average structure was calculated and regularized to give a 
structure representative of the ensemble. Statistics for the final structure set are presented in 
Appendix 7.3. A preliminary structure for cU3S∆ was also calculated during validation of the 
recently published CoMAND method of NMR structure determination (ElGamacy et al. 
2019). Briefly, this method uses spectral decomposition of CNH-NOESY spectra to derive 
local conformational parameters, providing input for de novo folding routines (in this case 
Rosetta (Das and Baker 2008)). Convergence is monitored by a quantitative R-factor 
expressing the match between back-calculated CNH-NOESY spectra and the 2 experimental 
spectrum. This structure therefore provides independent confirmation of the cU3S∆ fold, with 
an RMSD of 1.98 Å to the refined structure presented here. 
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6.19.  Binding assays 
 
6.19.1.   Analytical gel filtration in presence of cobalamins 
 
A pure UShsMMap02 protein sample  at 80 µM was mixed 1:1 with a buffer-containing 
either OHClb, CNCbl, MeCbl or S-AdoCbl at 40 mM and incubated on ice for 30 min. After 
this time, the protein-ligand sample was centrifuged at 18000 rpm at 4C to eliminate possible 
aggregates and the supernatant was loaded onto an analytical gel filtration column. The 
observed peaks for free Cbl and Cbl-protein complex were collected and analyzed 
photometrically at 351 (Cbl) and 280 nm (protein), respectively. The samples were contained 
in 20 mM Tris at pH 7.4, 100 mM NaCl and 1 mM "-mcaptoEtOH. 
 
6.19.2.  Aerobic  UV-vis monitoring of free cobalamin Vs. bound cobalamin 
 
Free cobalamin samples were prepared in the corresponding protein buffer at a 
concentration of 4 mM. An aliquot was diluted to 40 µM to record the spectra. Protein-Cbl 
complex was recorded right after eluting from analytical gel filtration, diluting when required. 
All spectra were recorded on a Varian Cary 50 Scan UV-VIS spectrometer.  
6.19.3.  Isothermal titration calorimetry  
 
A UShsMMap02 protein sample (300 µl) at 282 µM was titrated with a cyanocobalamin 
solution at 3 mM in steps of 2 µl injections with spacing of 300 sec between each injection. 
The protein was contained in 20 mM TRIS (pH 7.4), 100 mM NaCl and 1 mM β-
mercaptoethanol. The measurements were carried out on a TA Instruments nano ITC LV 
calorimeter in a 191µL sample cell. The sample cell was overloaded with 300µL of protein 
sample. All samples were degassed and temperature was equilibrated for 30min before the 
measurement. 
 
6.19.4.  Anaerobic size exclusion chromatography 
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Buffers and reagents were anoxically prepared in an anaerobic Glove Box from Coy Lab (© 
MR) in the laboratory of Holger Dobbek at HU Berlin. A Stock solution of 4 mM OHCbl and 
200 mM ascorbic acid were prepared in 100 mM KP buffer at pH8 and 300 mM KCl. 30 µl of 
the ascorbic acid solution (20 mM end concentration)  were added to 270 µl of the OHCbl 
solution (3.6 mM end concentration). The mixture immediately turned orange, indicating the 
successful reduction of cobalamin with ascorbic acid. The reduced cofactor sample was given 
to a protein sample at a concentration of 1.5 mM and loaded onto a 5 ml-bench gel filtration 
column for separation of the protein-cofactor complex. The eluting fractions were deposited 1 
ml each in 1.5 ml Eppendorf containers.  
 
6.19.5. Cobalamin titration with imidazole 
 
40 µM OHCb contained in water were titrated in steps of 2 µM (2  µl injections) of imidazole 
(3 mM) and followed photometrically in a 200 - 700 nm range on a Varian Cary 50 Scan UV-
VIS spectrometer. 
 
6.19.6. Cobalamin titration with beta-mercaptoethanol  
 
40 µM OHCb contained in water were titrated in steps of 4 µM (2 µl injections) with a beta-
mercaptoethanol previously diluted in water. The measurement was followed photometrically 
in a 200 - 700 nm range on a Varian Cary 50 Scan UV-VIS spectrometer. 
 
 
6.20.  Synthesis of ɑ-ribazole-3’-phosphate (by Bruce Lichtenstein)  
 
The synthesis of ɑR3P was carried out by hydrolyzing cyanocobalamin (Figure 6.1) after 
protocols described in the literature (Lezius and Barker 1965; K. L. Brown and Hakimi 1986). 
Hereby, cyanocobalamin (CNCbl) (2 g, 1.48 mmol) was dissolved in 75 mL perchloric acid 
and stirred for 3 hours in the dark. The reaction was transferred to a large beaker in ice 
equipped with a magnetic stir bar. 75 mL ice cold water was added to the solution with 
stirring. The solution pH was adjusted to 0 – checked by pH paper – by dropwise addition of 
10 M NaOH. Once at pH 0, approximately 1 g of Tris was added to aid in buffering at 
elevated pH. To remove the excess perchlorate as precipitate, the beaker is equipped with a 
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pH electrode and with rigorous stirring, aliquots of 2 M KOH were added carefully until the 
solution reached a pH of 8-8.5. The solution was stored overnight at 4 ºC to further the 
precipitation. The obtained precipitate was filtered and washed with ice cold water 
(approximately 50 mL) until no red color was observed. To remove additional potassium 
perchlorate, the filtrate was concentrated in vacuo, cooled overnight at 4 ºC and again filtered. 
The filtered solution was loaded onto a Dowex-22 formate column connected to an Akta 
FPLC. Weakly associated red hydrolysis products were washed from the column with 50 mM 
acetic acid (3.5 L) and crude phosphorylated products (including a majority ɑ-ribazole 3’-
phosphate) were eluted with 20 mM HCl (approximately 1-1.5 L). Elution with 20 mM HCl 
was monitored at 280 nm and fractions containing substantial amounts of absorbing species 
are combined. The combined eluant is freeze-dried. The slightly pink dry material was 
dissolved in water with 0.1% formic acid and loaded in batches onto pre-equilibrated Sep Pak 
C18 columns attached to an Akta FPLC. The Sep Pak C18 columns were washed with 0.1% 
formic acid in water and 0.1% formic acid in 95/5 water/acetonitrile while monitoring at 280 
nm to ensure a return to baseline. ɑR3P was eluted with 0.1% formic acid in 90/10 
water/acetonitrile. After recrystallization from boiling water and acetone, 213 mg ɑR3P were 
obtained (0.594 mmol, 40%) as the zwitterion. The compound validation was checked by 
NMR and mass spectrometry (Appendix 7.11 to 12).  
 
 
 
Figure 6.1 Synthesis of ɑ-ribazole-3’-phosphate from cyanocobalamin hydrolysis with perchloric acid 
(HClO4).   
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7.  Appendix 
7.1.  Homologous fragments across folds.  
Folds sharing homologous regions with probability scores above 80% have been plotted for the ɑ/β-class of 
SCOP. The number of hits (numbers in squares) is considerably higher for certain member than others because 
they are overrepresented in the pdb database. 
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7.2 Distribution of the HHsearch hits obtained for the ɑ/β folds of SCOP.  
The obtained hits were filtered at 80% probability. The most populated length is observed at around 30 residues. 
However fragments with larger lengths spread further to domain-sized regions. For instance, flavodoxin-like 
(green, circa 115 residues) matches twice to the hemD-like fold (orange, circa 250 residues) and the periplasmic-
binding protein-like I (purple, circa 300 residues) also matches nearly the entire hemD-like domain.  
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7.3. NMR refinement statistics for cU3SΔ structure  
 
8 Violations are expressed as RMSD ± SD unless otherwise stated. Numbers in brackets indicate the number of 
restraints of each type. 
9 Persistent violations are defined as those occurring in at least 75% of all structures. The thresholds at which no 
persistent violations occur are tabulated. 
10 3 Hydrogen bonds were treated as pseudo-covalent bonds. Deviations are expressed as the average 
distance/average deviation from linearity for restrained hydrogen bonds. 
 SA <SA>r 
Restraint Violations8   
Distance restraints (Å)   
All (676) 0.013 ± 0.001 0.013 
Intra-residue (98) 0.004 ± 0.001 0.004 
Inter-residue sequential (192) 0.016 ± 0.001 0.016 
Medium range (85) 0.018 ± 0.001 0.016 
Long range (225) 0.014 ± 0.001 0.015 
H-bond (76) 0.000 ± 0.000 0.000 
Persistent viol. thres.2 0.075 - 
Dihedral restraints (°)   
All (347) 0.047 ± 0.005 0.045 
Persistent viol. thres.9 0.25  
H-bond restraints10   
Distance (Å) (76) 2.18 ± 0.11  2.13 ± 0.12 
Antecedent angle (°) 13.0 ± 5.1 13.7 ± 5.7 
Covalent Geometry   
Bonds (Å × 10E-3) 2.66 ± 0.03 2.65 
Angles (°) 0.65 ± 0.01 0.65  
Impropers (°) 1.27 ± 0.03 1.22 
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11 3 Hydrogen bonds were treated as pseudo-covalent bonds. Deviations are expressed as the average 
distance/average deviation from linearity for restrained hydrogen bonds. 
 
12 Structures are labeled as follows: SA, the final set of 20 simulated annealing structures; <SA>, the mean 
structure calculated by averaging the coordinates of SA structures after fitting over secondary structure elements; 
<SA>r, the structure obtained by regularizing the mean structure under experimental restraints. RMSD values 
were obtained based on superimpositions over ordered residue (defined as P3-L118). 
Structure Quality Indicators11   
Ramachandran Map (%) 99.1 / 0.9 / 0.0  
Atomic R.M.S.D (Å)12   
 Backbone Heavy Atom All Heavy Atom 
SA vs <SA> 0.27 ± 0.06 0.86 ± 0.06 
SA vs <SA>r 0.36 ± 0.05 1.04 ± 0.08 
<SA> vs <SA>r 0.24 0.72 
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7.4. Refinement statistics for UShsMMap01      
 
  
Protein 
Wavelength 
Resolution range 
Space group 
Unit cell (Å, °) 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
CC(work) 
CC(free) 
Number of non-hydrogen atoms 
macromolecules 
solvent 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashscore 
Average B-factor 
macromolecules 
solvent 
Number of TLS groups 
UShsMMap01 
1.0000 
33.0 - 2.0 (2.0 - 2.0) 
P 1 21 1 
49.589 43.196 65.664 90 108.218 90 
52908 (4903) 
17758 (1750) 
3.0 (2.8) 
98.70 (97.55) 
12.60 (2.19) 
24.96 
0.07722 (0.5379) 
0.09426 (0.6626) 
0.05337 (0.3822) 
0.997 (0.757) 
0.999 (0.928) 
17752 (1750) 
888 (87) 
0.19 (0.26) 
0.24 (0.33) 
0.962 (0.829) 
0.933 (0.746) 
2331 
2093 
238 
272 
0.016 
1.18 
97.41 
2.22 
0.37 
0 
6.09 
33.84 
33.31 
38.56 
3 
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7.5. Refinement statistics for UShsMMap02 
 
  
Protein 
Wavelength 
Resolution range 
Space group  
Unit cell (Å, °) 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
CC(work) 
CC(free) 
Number of non-hydrogen atoms 
macromolecules 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashscore 
Average B-factor 
macromolecules 
Number of TLS groups 
UShsMMap02 
1.0000 
37.0 - 2.7 (2.8 - 2.7) 
P 1 21 1 
49.685 42.486 64.295 90 96.883 90 
51018 (4944) 
7723 (726) 
6.6 (6.5) 
99.16 (94.63) 
11.61 (1.15) 
78.28 
0.08823 (1.207) 
0.096 (1.313) 
0.03733 (0.5109) 
0.998 (0.712) 
0.999 (0.912) 
7686 (723) 
385 (36) 
0.23 (0.37) 
0.28 (0.31) 
0.959 (0.736) 
0.907 (0.726) 
2087 
2087 
272 
0.015 
1.5 
90.74 
6.67 
2.59 
0.44 
19.51 
98.04 
98.04 
3 
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7.6. Refinement statistics for UShsMMap03 
Protein 
Wavelength 
Resolution range 
Space group 
Unit cell (Å, °) 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
UShsMMap03 
1.0000 
38.0 - 2.2 (2.3 - 2.2) 
P 1 21 1 
48.348 42.668 60.61 90 92.044 90 
82631 (7117) 
12602 (1168) 
6.6 (6.1) 
98.98 (93.74) 
10.54 (1.70) 
47.62 
0.09053 (1.2) 
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R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
CC(work) 
CC(free) 
Number of non-hydrogen atoms 
macromolecules 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashscore 
Average B-factor 
macromolecules 
Number of TLS groups 
0.09857 (1.313) 
0.03849 (0.5241) 
0.998 (0.677) 
0.999 (0.898) 
12601 (1168) 
631 (59) 
0.22 (0.39) 
0.25 (0.41) 
0.965 (0.712) 
0.924 (0.568) 
2100 
2100 
273 
0.02 
2.11 
91.88 
7.01 
1.11 
21.24 
30.43 
68.57 
68.57 
3 
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7.7. Refinement statistics for UShsMMap04 
Protein 
Wavelength 
Resolution range 
Space group 
Unit cell (Å, °) 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
Number of non-hydrogen atoms 
macromolecules 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashscore 
Average B-factor 
macromolecules 
Number of TLS groups 
UShsMMap04 
1.0000 
41.0 - 2.4 (2.6 - 2.4) 
P 1 21 1 
70.546 47.294 88.102 90 103.354 90 
138600 (11296) 
21373 (1902) 
6.5 (5.9) 
98.23 (88.25) 
11.12 (1.31) 
51.23 
0.1161 (1.151) 
0.1265 (1.259) 
0.04958 (0.5036) 
0.998 (0.659) 
1 (0.891) 
21313 (1901) 
1067 (95) 
0.24 (0.29) 
0.30 (0.37) 
3709 
3709 
521 
0.010 
1.52 
86.25 
9.43 
4.32 
1.68 
10.38 
75.61 
75.61 
6 
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7.8. Refinement statistics for UShsMMap02 in complex with DMB  
Protein 
Wavelength 
Resolution range 
Space group 
Unit cell (Å, °) 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
CC(work) 
CC(free) 
Number of non-hydrogen atoms 
macromolecules 
ligands 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashsscore 
Average B-factor 
macromolecules 
ligands 
Number of TLS groups 
UShsMMap02 (DMB co-crystallization) 
1.0000 
49.0 - 2.7 (2.8 - 2.7) 
P 1 21 1 
49.717 42.698 64.935 90 96.948 90 
26856 (2547) 
7706 (736) 
3.5 (3.4) 
99.03 (96.07) 
8.92 (1.33) 
70.17 
0.07745 (0.8707) 
0.0917 (1.041) 
0.04845 (0.5626) 
0.997 (0.747) 
0.999 (0.925) 
7683 (733) 
383 (36) 
0.23 (0.4015) 
0.26 (0.4342) 
0.947 (0.741) 
0.952 (0.707) 
2107 
2096 
11 
273 
0.004 
0.67 
91.88 
7.75 
0.37 
0 
7.69 
95.62 
95.62 
96.56 
3 
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7.9. Refinement statistics for UShsMMap02 in complex with PEG 
Protein 
Wavelength 
Resolution range 
Space group 
Unit cell 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
CC(work) 
CC(free) 
Number of non-hydrogen atoms 
macromolecules 
ligands 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashscore 
Average B-factor 
macromolecules 
ligands 
Number of TLS groups 
UShsMMap02-PEG (DMB soaking) 
1.0000 
40.0 - 2.4 (2.5 - 2.4) 
P 1 21 1 
48.412 42.826 63.12 90 94.921 90 
47121 (4370) 
10588 (963) 
4.5 (4.5) 
98.25 (91.11) 
8.43 (0.35) 
63.98 
0.1269 (3.547) 
0.1445 (4.023) 
0.06752 (1.862) 
0.998 (0.169) 
0.999 (0.538) 
10557 (963) 
528 (48) 
0.25 (0.53) 
0.26 (0.51) 
0.960 (0.419) 
0.959 (0.476) 
2103 
2096 
7 
273 
0.016 
1.9 
91.14 
7.01 
1.85 
18.14 
10.4 
90.74 
90.81 
68.22 
3 
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7.10. Refinement statistics for UShsMMap02 in complex with PEG 
Protein 
Wavelength 
Resolution range 
Space group 
Unit cell (Å, °) 
Total reflections 
Unique reflections 
Multiplicity 
Completeness (%) 
Mean I/sigma(I) 
Wilson B-factor 
R-merge 
R-meas 
R-pim 
CC1/2 
CC* 
Reflections used in refinement 
Reflections used for R-free 
R-work 
R-free 
CC(work) 
CC(free) 
Number of non-hydrogen atoms 
macromolecules 
ligands 
Protein residues 
RMS(bonds) 
RMS(angles) 
Ramachandran favored (%) 
Ramachandran allowed (%) 
Ramachandran outliers (%) 
Rotamer outliers (%) 
Clashscore 
Average B-factor 
macromolecules 
ligands 
Number of TLS groups 
UShsMMap02-PEG (αR3P soaking) 
1.000 
39.0 - 2.3 (2.3 - 2.2) 
P 1 21 1 
48.437 42.42 62.022 90 93.308 90 
52495 (3969) 
11884 (1079) 
4.4 (3.7) 
98.04 (90.28) 
10.69 (0.72) 
51.28 
0.08584 (1.61) 
0.09738 (1.877) 
0.04495 (0.9398) 
0.999 (0.481) 
1 (0.806) 
11862 (1077) 
594 (54) 
0.24 (0.42) 
0.26 (0.41) 
0.961 (0.646) 
0.898 (0.519) 
2094 
2087 
7 
272 
0.016 
2.03 
93.7 
5.56 
0.74 
17.78 
18.74 
72.82 
72.85 
65.9 
3 
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7.11. Compound validation of alpha-ribazole-3’-phosphate by NMR (by Bruce 
Lichtenstein) 13 
 
 
 
 
= 
 
 
13 NMR 1H (500 MHz, D2O, neutral pH) 2.29 (s, 3H); 2.31 (s, 3H); 3.76 (dd,1H, J1=12.70 Hz, 
J2=4.40 Hz); 3.83 (dd, 1H, J1=12.70 Hz, J2=3.13 Hz); 4.41 (ap. q, 1H, J=4.46 Hz); 4.61 (ap. 
m, 2H); 6.35 (d, 1H, J=4.27 Hz); 7.38 (s, 1H); 7.46 (s, 1H); 8.32 (s, 0.5H owing to exchange); 
13C (125 MHz, D2O, neutral pH)21.915; 22.189; 63.760; 74.104 (J=2.47 Hz); 75.662 (J=4.54 
Hz); 85.864 (J=5.45 Hz); 85.864 (J=5.45 Hz); 113.771; 121.279; 134.218 (J=1.82 Hz); 
135.218; 136.084; 142.924 (J=2.72 Hz); 145.699.  
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7.12. Compound validation of alpha-ribazole-3’-phosphate by mass spectrometry 
(LRMS)14 (by Bruce Lichtenstein) 
 
 
 
 
 
 
  
 
14 LRMS: 359.16 m/z (Expected 359.09 m/z). 
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